Patent Application
20170166931
The present invention relates generally to metabolic and biosynthetic processes and microbial organisms capable of producing organic compounds, and more specifically to non-naturally occurring microbial organisms having an organic compound pathway, such as butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and 2,4-pentadienoate.
Over 25 billion pounds of butadiene (1,3-butadiene, “BD”) are produced annually and is applied in the manufacture of polymers such as synthetic rubbers and ABS resins, and chemicals such as hexamethylenediamine and 1,4-butanediol. For example, butadiene can be reacted with numerous other chemicals, such as other alkenes, e.g. styrene, to manufacture numerous copolymers, e.g. acrylonitrile 1,3-butadiene styrene (ABS), styrene-1,3-butadiene (SBR) rubber, styrene-1,3-butadiene latex. These materials are used in rubber, plastic, insulation, fiberglass, pipes, automobile and boat parts, food containers, and carpet backing. Butadiene is typically produced as a by-product of the steam cracking process for conversion of petroleum feedstocks such as naphtha, liquefied petroleum gas, ethane or natural gas to ethylene and other olefins.
The ability to manufacture butadiene from alternative and/or renewable feedstocks would represent a major advance in the quest for more sustainable chemical production processes.
One possible way to produce butadiene renewably involves fermentation of sugars or other feedstocks to produce diols, such as 1,4-butanediol or 1,3-butanediol, which are separated, purified, and then dehydrated to butadiene in a second step involving metal-based catalysis.
Direct fermentative production of butadiene from renewable feedstocks would obviate the need for dehydration steps and butadiene gas (bp—4.4° C.) would be continuously emitted from the fermenter and readily condensed and collected. Developing a fermentative production process would eliminate the need for fossil-based butadiene and would allow substantial savings in cost, energy, and harmful waste and emissions relative to petrochemically-derived butadiene.
Crotyl alcohol (“CrotOH”), also referred to as 2-buten-1-ol, is a valuable chemical intermediate. It serves as a precursor to crotyl halides, esters, and ethers, which in turn are chemical intermediates in the production of monomers, fine chemicals, agricultural chemicals, and pharmaceuticals. Exemplary fine chemical products include sorbic acid, trimethylhydroquinone, crotonic acid and 3-methoxybutanol. CrotOH is also a precursor to 1,3-butadiene. CrotOH is currently produced exclusively from petroleum feedstocks. For example Japanese Patent 47-013009 and U.S. Pat. Nos. 3,090,815, 3,090,816, and 3,542,883 describe a method of producing CrotOH by isomerization of 1,2-epoxybutane. The ability to manufacture CrotOH from alternative and/or renewable feedstocks would represent a major advance in the quest for more sustainable chemical production processes.
3-Buten-2-ol (also referenced to as methyl vinyl carbinol (“MVC”)) is an intermediate that can be used to produce butadiene. There are significant advantages to use of MVC over 1,3-BDO because there are fewer separation steps and only one dehydration step. MVC can also be used as a solvent, a monomer for polymer production, or a precursor to fine chemicals. Accordingly, the ability to manufacture MVC from alternative and/or renewable feedstock would again present a significant advantage for sustainable chemical production processes.
2,4-Pentadienoate is a useful substituted butadiene derivative in its own right and a valuable intermediate en route to other substituted 1,3-butadiene derivatives, including, for example, 1-carbamoyl-1,3-butadienes which are accessible via Curtius rearrangement. The resultant N-protected-1,3-butadiene derivatives can be used in Diels alder reactions for the preparation of substituted anilines. 2,4-Pentadienoate can be used in the preparation of various polymers and co-polymers.
Thus, there exists a need for alternative methods for effectively producing commercial quantities of compounds such as butadiene, CrotOH, MVC or 2,4-pentadienoate. The present invention satisfies this need and provides related advantages as well.
In embodiments the invention provides a non-naturally occurring microbial organism having a pathway to butadiene, crotyl alcohol, 2,4-pentadienoate, or 3-buten-2-ol, said microbial organism comprising at least one exogenous nucleic acid encoding a pathway enzyme, wherein the enzyme is selected from the group consisting of (1E) 4-hydroxy 2-oxovalerate decarboxylase, (1 D) 3-hydroxybutyraldehyde dehydratase, (1N) 2-oxopent-3-enoyl-CoA synthetase or transferase, (1O) 2-oxopent-3-enoyl-CoA reductase, (1P) 2-hydroxypent-3-enoyl-CoA dehydratase/vinylisomerase, (1R) 2-hydroxypent-3-enoyl-CoA synthetase or transferase, (1F) 2-oxopent-3-enoate reductase, (1U) 2-hydroxypent-3-enoate vinylisomerase, and (1K) crotyl alcohol vinylisomerase. One or more additional pathway enzymes may be included in the microbial organism. The invention also provides methods for the production of butadiene, crotyl alcohol, 2,4-pentadienoate, or 3-buten-2-ol, comprising culturing the non-naturally occurring microorganism.
In other embodiments the invention provides a non-naturally occurring microbial organism having a pathway to butadiene, crotyl alcohol, 2,4-pentadienoate, or 3-buten-1-ol, said microbial organism comprising at least one exogenous nucleic acid encoding a pathway enzyme, the enzyme selected from the group consisting of (2E) 2-hydroxypent-4-enoate vinylisomerase, (2H) 2-hydroxypent-4-enoate mutase, and (2M) 3-hydroxypent-4-enoyl-CoA vinylisomerase. One or more additional pathway enzymes may be included in the microbial organism. The invention also provides methods for the production of butadiene, crotyl alcohol, 2,4-pentadienoate, or 3-buten-1-ol, comprising culturing the non-naturally occurring microorganism.
In other embodiments the invention provides a non-naturally occurring microbial organism having a pathway to butadiene, 2,4-pentadienoate, or 3-buten-2-ol, said microbial organism comprising at least one exogenous nucleic acid encoding a pathway enzyme, the enzyme selected from the group consisting of (3D) 3,4-dihydroxypentanoate dehydratase, (3E) 4-hydroxypent-2-enoate decarboxylase (3H) 3,4-dihydroxypentanoyl-CoA dehydratase, and (3J) 4-hydroxypent-2-enoyl-CoA transferase. The invention also provides methods for the production of butadiene, crotyl alcohol, 2,4-pentadienoate, or 3-buten-2-ol, comprising culturing the non-naturally occurring microorganism.
In other embodiments the invention provides a non-naturally occurring microbial organism having a pathway to convert crotyl alcohol to butadiene or 3-buten-2-ol, said microbial organism comprising at least one exogenous nucleic acid encoding a pathway enzyme, wherein the enzyme is selected from the group consisting of (4D) 3-buten-2-ol synthase, (4E) 3-buten-2-ol synthase, or (4F) crotyl alcohol isomerase.
The product pathways described herein are specifically contemplated for use in the organisms, compositions and their uses, such as in methods to make the target products of 1,3-butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol or 2,4-pentadienoate or other product, and other embodiments as taught herein.
Embodiments of the disclosure are directed to the design of metabolic pathways, and the production and use of non-naturally occurring microbial organisms capable of producing butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol and/or 2,4-pentadienoate. As disclosed herein, metabolic pathways can be designed and recombinantly engineered to achieve the biosynthesis of butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate in microbial organisms such as Escherichia coli and other cells or organisms. Biosynthetic production of butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate can be performed by construction and fermentation of strains having the designed metabolic genotype.
With reference to
With reference to
With reference to
In some embodiments, at least one of the pathway enzymes is encoded by nucleic acid that is heterologous to the host species. For example, the heterologous nucleic acid can be obtained from a microbial species other than the host species, such as a nucleic acid from a bacteria other than E. coli (i.e., a non-E. coli bacteria), wherein the heterologous nucleic acid is transformed into E. coli host organism to create any of the pathways of the disclosure. In some embodiments, two, three, four, five, six, etc., heterologous nucleic acids from one or more bacteria other than the host bacteria, are transformed into the bacterial host organism to create any of the pathways of the disclosure. For example, to create a pathway such as BEFUVH in a host organism, one can first determine what, if any, enzymes of the BEFUVH are naturally present in a desired host species. If B is native to the host species, but not EFUVH, the host can then be transformed with heterologous nucleic acids encoding EFUVH to create a pathway in the cell to form butadiene. This approach can be used to create a non-naturally occurring microbial organism having a pathway to butadiene, crotyl alcohol, 2,4-pentadienoate, or 3-buten-2-ol, having any of the pathways of the disclosure.
As shown in
With reference to
With reference to
For example, step A of
For example, step B of
With reference to
In one embodiment for each pathway or step above is also contemplated the substitution of any one or more of subsets of enzymes described as Steps 1L, 1V, 1M, 2C, 2F, 2O, 2N, 2Q, 2R, 3F, 3K, 3M, 4A, 4B, 4C, 4G and 4H for its corresponding step (e.g. replace enzymes described for Step 1L with those described for Step 1L*).
With reference to
With reference to
Also specifically contemplated herein as unique transformations of
With reference to
Bacillus subtilis
Saccharomyces serevisiae
Staphylococcus aureus
Pyrococcus horikoshii OT3
Enterococcus faecalis V583
Streptococcus pneumoniae
Lactobacillus plantarum
Citrobacter rodentium
Salmonella enterica
Rhizobium leguminosarum
Escherichia coli str.
Exemplary candidate thiamine kinases for
Escherichia coli K12
Salmonella enterica subsp.
enterica serovar
Typhimurium str. LT2
Exemplary fuculokinases for
Escherichia coli K12
Salmonella enterica subsp.
enterica serovar
Typhimurium str.
Citrobacter freundii ATCC
Exemplary 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase for
Escherichia coli K12
Enterococcus faecalis V583
Exemplary pantothenate kinases for
Mycobacterium
tuberculosis H37Rv
Escherichia coli K12
Thermotoga maritima
Staphylococcus aureus
Exemplary 4-(cytidine 5′-diphospho)-2-C-methyl-D-erythritol kinases (2.7.1.148) for
Escherichia coli K12
Mycobacterium tuberculosis
Step A subset of synthases (alkene forming) for
The enzyme-subsets designated as steps 1L, 1V, 1M, 2C, 2F, 2O, 2N, 2Q, 2R, 3F, 3K, 3M, 4G and 4H of dehydratase of the EC 4.2.1.a class for their respective Steps 1L, 1V, 1M, 2C, 2F, 2O, 2N, 2Q, 2R, 3F, 3K, 3M, 4G and 4H include the exemplary dehydratases of the 4.2.1.a class shown in the table below as well as a dehydratase class that dehydrates phenyllactyl-CoA to cinnamoyl-CoA exemplified by the dehydratase found in Clostridium sporogens that dehydrates phenyllactyl-CoA to cinnamoyl-CoA. This enzyme is composed of three subunits, one of which is a CoA transferase. The first step comprises of a CoA transfer from cinnamoyl-CoA to phenyllactate leading to the formation of phenyllactyl-CoA and cinnamate. The product cinnamate is released. The dehydratase then converts phenyllactyl-CoA into cinnamoyl-CoA. The FldA is the CoA transferase and FldBC are alpha and beta subunits of the dehydratase, which are realted to component D from A. fermentans.
Clostridum symbiosum
Clostridum symbiosum
Clostridum symbiosum
Fusobacterium nucleatum
Fusobacterium nucleatum
Fusobacterium nucleatum
Clostridium sporogens
Clostridium sporogens
Colletotrichum
gloeosporioides Nara gc5
Togninia minima
Neofusicoccum parvum
Further enzymes of
Methanococcus jannaschii
Pseudomonas putida
Enzymes with dehydratase and vinylisomerase activity suitable for
Colletotrichum
gloeosporioides
Togninia minima
Neofusicoccum parvum
As used herein, the term “non-naturally occurring” when used in reference to a microbial organism or microorganism of the invention is intended to mean that the microbial organism has at least one genetic alteration not normally found in a naturally occurring strain of the referenced species, including wild-type strains of the referenced species. Genetic alterations include, for example, modifications introducing expressible nucleic acids encoding metabolic polypeptides, other nucleic acid additions, nucleic acid deletions and/or other functional disruption of the microbial organism's genetic material. Such modifications include, for example, coding regions and functional fragments thereof, for heterologous, homologous or both heterologous and homologous polypeptides for the referenced species. Additional modifications include, for example, non-coding regulatory regions in which the modifications alter expression of a gene or operon. Exemplary metabolic polypeptides include enzymes or proteins within a butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate biosynthetic pathway.
A metabolic modification refers to a biochemical reaction that is altered from its naturally occurring state. Therefore, non-naturally occurring microorganisms can have genetic modifications to nucleic acids encoding metabolic polypeptides, or functional fragments thereof. Exemplary metabolic modifications are disclosed herein.
As used herein, the term “isolated” when used in reference to a microbial organism is intended to mean an organism that is substantially free of at least one component as the referenced microbial organism is found in nature. The term includes a microbial organism that is removed from some or all components as it is found in its natural environment. The term also includes a microbial organism that is removed from some or all components as the microbial organism is found in non-naturally occurring environments. Therefore, an isolated microbial organism is partly or completely separated from other substances as it is found in nature or as it is grown, stored or subsisted in non-naturally occurring environments. Specific examples of isolated microbial organisms include partially pure microbes, substantially pure microbes and microbes cultured in a medium that is non-naturally occurring.
As used herein, the terms “microbial,” “microbial organism” or “microorganism” are intended to mean any organism that exists as a microscopic cell that is included within the domains of archaea, bacteria or eukarya. Therefore, the term is intended to encompass prokaryotic or eukaryotic cells or organisms having a microscopic size and includes bacteria, archaea and eubacteria of all species as well as eukaryotic microorganisms such as yeast and fungi. The term also includes cell cultures of any species that can be cultured for the production of a biochemical.
As used herein, the term “CoA” or “coenzyme A” is intended to mean an organic cofactor or prosthetic group (nonprotein portion of an enzyme) whose presence is required for the activity of many enzymes (the apoenzyme) to form an active enzyme system. Coenzyme A functions in certain condensing enzymes, acts in acetyl or other acyl group transfer and in fatty acid synthesis and oxidation, pyruvate oxidation and in other acetylation.
As used herein, the term “substantially anaerobic” when used in reference to a culture or growth condition is intended to mean that the amount of oxygen is less than about 10% of saturation for dissolved oxygen in liquid media. The term also is intended to include sealed chambers of liquid or solid medium maintained with an atmosphere of less than about 1% oxygen.
“Exogenous” as it is used herein is intended to mean that the referenced molecule or the referenced activity is introduced into the host microbial organism. The molecule can be introduced, for example, by introduction of an encoding nucleic acid into the host genetic material such as by integration into a host chromosome or as non-chromosomal genetic material such as a plasmid. Therefore, the term as it is used in reference to expression of an encoding nucleic acid refers to introduction of the encoding nucleic acid in an expressible form into the microbial organism. When used in reference to a biosynthetic activity, the term refers to an activity that is introduced into the host reference organism. The source can be, for example, a homologous or heterologous encoding nucleic acid that expresses the referenced activity following introduction into the host microbial organism. Therefore, the term “endogenous” refers to a referenced molecule or activity that is present in the host. Similarly, the term when used in reference to expression of an encoding nucleic acid refers to expression of an encoding nucleic acid contained within the microbial organism. The term “heterologous” refers to a molecule or activity derived from a source other than the referenced species whereas “homologous” refers to a molecule or activity derived from the host microbial organism. Accordingly, exogenous expression of an encoding nucleic acid of the invention can utilize either or both a heterologous or homologous encoding nucleic acid.
It is understood that when more than one exogenous nucleic acid is included in a microbial organism that the more than one exogenous nucleic acids refers to the referenced encoding nucleic acid or biosynthetic activity, as discussed above. It is further understood, as disclosed herein, that such more than one exogenous nucleic acids can be introduced into the host microbial organism on separate nucleic acid molecules, on polycistronic nucleic acid molecules, or a combination thereof, and still be considered as more than one exogenous nucleic acid. For example, as disclosed herein a microbial organism can be engineered to express two or more exogenous nucleic acids encoding a desired pathway enzyme or protein. In the case where two exogenous nucleic acids encoding a desired activity are introduced into a host microbial organism, it is understood that the two exogenous nucleic acids can be introduced as a single nucleic acid, for example, on a single plasmid, on separate plasmids, can be integrated into the host chromosome at a single site or multiple sites, and still be considered as two exogenous nucleic acids. Similarly, it is understood that more than two exogenous nucleic acids can be introduced into a host organism in any desired combination, for example, on a single plasmid, on separate plasmids, can be integrated into the host chromosome at a single site or multiple sites, and still be considered as two or more exogenous nucleic acids, for example three exogenous nucleic acids. Thus, the number of referenced exogenous nucleic acids or biosynthetic activities refers to the number of encoding nucleic acids or the number of biosynthetic activities, not the number of separate nucleic acids introduced into the host organism.
The non-naturally occurring microbal organisms of the invention can contain stable genetic alterations, which refers to microorganisms that can be cultured for greater than five generations without loss of the alteration. Generally, stable genetic alterations include modifications that persist greater than 10 generations, particularly stable modifications will persist more than about 25 generations, and more particularly, stable genetic modifications will be greater than 50 generations, including indefinitely.
Those skilled in the art will understand that the genetic alterations, including metabolic modifications exemplified herein, are described with reference to a suitable host organism such as E. coli and their corresponding metabolic reactions or a suitable source organism for desired genetic material such as genes for a desired metabolic pathway. However, given the complete genome sequencing of a wide variety of organisms and the high level of skill in the area of genomics, those skilled in the art will readily be able to apply the teachings and guidance provided herein to essentially all other organisms. For example, the E. coli metabolic alterations exemplified herein can readily be applied to other species by incorporating the same or analogous encoding nucleic acid from species other than the referenced species. Such genetic alterations include, for example, genetic alterations of species homologs, in general, and in particular, orthologs, paralogs or nonorthologous gene displacements.
An ortholog is a gene or genes that are related by vertical descent and are responsible for substantially the same or identical functions in different organisms. For example, mouse epoxide hydrolase and human epoxide hydrolase can be considered orthologs for the biological function of hydrolysis of epoxides. Genes are related by vertical descent when, for example, they share sequence similarity of sufficient amount to indicate they are homologous, or related by evolution from a common ancestor. Genes can also be considered orthologs if they share three-dimensional structure but not necessarily sequence similarity, of a sufficient amount to indicate that they have evolved from a common ancestor to the extent that the primary sequence similarity is not identifiable. Genes that are orthologous can encode proteins with sequence similarity of about 25% to 100% amino acid sequence identity. Genes encoding proteins sharing an amino acid similarity less that 25% can also be considered to have arisen by vertical descent if their three-dimensional structure also shows similarities.
Orthologs include genes or their encoded gene products that through, for example, evolution, have diverged in structure or overall activity. For example, where one species encodes a gene product exhibiting two functions and where such functions have been separated into distinct genes in a second species, the three genes and their corresponding products are considered to be orthologs. For the production of a biochemical product, those skilled in the art will understand that the orthologous gene harboring the metabolic activity to be introduced or disrupted is to be chosen for construction of the non-naturally occurring microorganism. An example of orthologs exhibiting separable activities is where distinct activities have been separated into distinct gene products between two or more species or within a single species.
In contrast, paralogs are homologs related by, for example, duplication followed by evolutionary divergence and have similar or common, but not identical functions. Paralogs can originate or derive from, for example, the same species or from a different species. For example, microsomal epoxide hydrolase (epoxide hydrolase I) and soluble epoxide hydrolase (epoxide hydrolase II) can be considered paralogs because they represent two distinct enzymes, co-evolved from a common ancestor, that catalyze distinct reactions and have distinct functions in the same species. Paralogs are proteins from the same species with significant sequence similarity to each other suggesting that they are homologous, or related through co-evolution from a common ancestor.
A nonorthologous gene displacement is a nonorthologous gene from one species that can substitute for a referenced gene function in a different species. Substitution includes, for example, being able to perform substantially the same or a similar function in the species of origin compared to the referenced function in the different species. Although generally, a nonorthologous gene displacement will be identifiable as structurally related to a known gene encoding the referenced function, less structurally related but functionally similar genes and their corresponding gene products nevertheless will still fall within the meaning of the term as it is used herein. Functional similarity requires, for example, at least some structural similarity in the active site or binding region of a nonorthologous gene product compared to a gene encoding the function sought to be substituted. Therefore, a nonorthologous gene includes, for example, a paralog or an unrelated gene.
Therefore, in identifying and constructing the non-naturally occurring microbial organisms of the invention having biosynthetic capability, those skilled in the art will understand with applying the teaching and guidance provided herein to a particular species that the identification of metabolic modifications can include identification and inclusion or inactivation of orthologs. To the extent that paralogs and/or nonorthologous gene displacements are present in the referenced microorganism that encode an enzyme catalyzing a similar or substantially similar metabolic reaction, those skilled in the art also can utilize these evolutionally related genes.
Orthologs, paralogs and nonorthologous gene displacements can be determined by methods well known to those skilled in the art. For example, inspection of nucleic acid or amino acid sequences for two polypeptides will reveal sequence identity and similarities between the compared sequences. Based on such similarities, one skilled in the art can determine if the similarity is sufficiently high to indicate the proteins are related through evolution from a common ancestor. Algorithms well known to those skilled in the art, such as Align, BLAST, Clustal W and others compare and determine a raw sequence similarity or identity, and also determine the presence or significance of gaps in the sequence which can be assigned a weight or score. Such algorithms also are known in the art and are similarly applicable for determining nucleotide sequence similarity or identity. Parameters for sufficient similarity to determine relatedness are computed based on well known methods for calculating statistical similarity, or the chance of finding a similar match in a random polypeptide, and the significance of the match determined. A computer comparison of two or more sequences can, if desired, also be optimized visually by those skilled in the art. Related gene products or proteins can be expected to have a high similarity, for example, 25% to 100% sequence identity. Proteins that are unrelated can have an identity which is essentially the same as would be expected to occur by chance, if a database of sufficient size is scanned (about 5%). Sequences between 5% and 24% may or may not represent sufficient homology to conclude that the compared sequences are related. Additional statistical analysis to determine the significance of such matches given the size of the data set can be carried out to determine the relevance of these sequences.
Exemplary parameters for determining relatedness of two or more sequences using the BLAST algorithm, for example, can be as set forth below. Briefly, amino acid sequence alignments can be performed using BLASTP version 2.0.8 (Jan. 5, 1999) and the following parameters: Matrix: 0 BLOSUM62; gap open: 11; gap extension: 1; x_dropoff: 50; expect: 10.0; wordsize: 3; filter: on. Nucleic acid sequence alignments can be performed using BLASTN version 2.0.6 (Sep. 16, 1998) and the following parameters: Match: 1; mismatch: −2; gap open: 5; gap extension: 2; x_dropoff: 50; expect: 10.0; wordsize: 11; filter: off. Those skilled in the art will know what modifications can be made to the above parameters to either increase or decrease the stringency of the comparison, for example, and determine the relatedness of two or more sequences.
It is understood that any of the pathways disclosed herein, as described in the Examples and exemplified in the pathways of
This invention is also directed, in part to engineered biosynthetic pathways to improve carbon flux through a central metabolism intermediate en route to butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate. The present invention provides non-naturally occurring microbial organisms having one or more exogenous genes encoding enzymes that can catalyze various enzymatic transformations en route to butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate. In some embodiments, these enzymatic transformations are used to improve product yields, including but not limited to, from carbohydrate-based carbon feedstock.
The one or more exogenous genes encoding enzymes that can catalyze various enzymatic transformations en route to butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate can be used in combination with genetic modifications that improve the amount of reducing equivalents available to the biosynthetic pathways, or that minimize loss of reducing equivalents and/or carbon to byproducts. In accordance with some embodiments, the one or more exogenous genes encoding enzymes that can catalyze various enzymatic transformations en route to butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate can be used in combination with genetic modifications that (i) enhance carbon fixation, and/or (ii) accessing additional reducing equivalents from carbon sources.
Reducing equivalents can come in the form of NADH, NADPH, FADH, reduced quinones, reduced ferredoxins, reduced flavodoxins and thioredoxins.
It is understood by those skilled in the art that the pathways described herein for increasing product yield can be combined with any of the pathways disclosed herein, including those pathways depicted in the figures. One skilled in the art will understand that, depending on the pathway to a desired product and the precursors and intermediates of that pathway, a particular pathway for improving product yield, as discussed herein and in the examples, or combination of such pathways, can be used in combination with a pathway to a desired product to increase the yield of that product or a pathway intermediate.
The invention is described herein with general reference to the metabolic reaction, reactant or product thereof, or with specific reference to one or more nucleic acids or genes encoding an enzyme associated with or catalyzing, or a protein associated with, the referenced metabolic reaction, reactant or product. Unless otherwise expressly stated herein, those skilled in the art will understand that reference to a reaction also constitutes reference to the reactants and products of the reaction. Similarly, unless otherwise expressly stated herein, reference to a reactant or product also references the reaction, and reference to any of these metabolic constituents also references the gene or genes encoding the enzymes that catalyze or proteins involved in the referenced reaction, reactant or product. Likewise, given the well-known fields of metabolic biochemistry, enzymology and genomics, reference herein to a gene or encoding nucleic acid also constitutes a reference to the corresponding encoded enzyme and the reaction it catalyzes or a protein associated with the reaction as well as the reactants and products of the reaction.
The non-naturally occurring microbial organisms of the invention can be produced by introducing expressible nucleic acids encoding one or more of the enzymes or proteins participating in one or more butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate biosynthetic pathways. Depending on the host microbial organism chosen for biosynthesis, nucleic acids for some or all of a particular butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate acid biosynthetic pathway can be expressed. For example, if a chosen host is deficient in one or more enzymes or proteins for a desired biosynthetic pathway, then expressible nucleic acids for the deficient enzyme(s) or protein(s) are introduced into the host for subsequent exogenous expression. Alternatively, if the chosen host exhibits endogenous expression of some pathway genes, but is deficient in others, then an encoding nucleic acid is needed for the deficient enzyme(s) or protein(s) to achieve butadiene, crotyl alcohol, 3-buten-1-ol, 3-buten-2-ol, and/or 2,4-pentadienoate biosynthesis. Thus, a non-naturally occurring microbial organism of the invention can be produced by introducing exogenous enzyme or protein activities to obtain a desired biosynthetic pathway or a desired biosynthetic pathway can be obtained by introducing one or more exogenous enzyme or protein activities that, together with one or more endogenous enzymes or proteins, produces a desired product such as butadiene.
Host microbial organisms can be selected from, and the non-naturally occurring microbial organisms generated in, for example, bacteria, yeast, fungus or any of a variety of other microorganisms applicable to fermentation processes. Exemplary bacteria include species selected from Escherichia coli, Klebsiella oxytoca, Anaerobiospirillum succiniciproducens, Actinobacillus succinogenes, Mannheimia succiniciproducens, Rhizobium etli, Bacillus subtilis, Corynebacterium glutamicum, Gluconobacter oxydans, Zymomonas mobilis, Lactococcus lactis, Lactobacillus plantarum, Streptomyces coelicolor, Clostridium acetobutylicum, Pseudomonas fluorescens, and Pseudomonas putida. Exemplary yeasts or fungi include species selected from Saccharomyces cerevisiae, Schizosaccharomyces pombe, Kluyveromyces lactis, Kluyveromyces marxianus, Aspergillus terreus, Aspergillus niger, Pichia pastoris, Rhizopus arrhizus, Rhizopus oryzae, Yarrowia lipolytica, and the like. E. coli is a particularly useful host organism since it is a well characterized microbial organism suitable for genetic engineering. Other particularly useful host organisms include yeast such as Saccharomyces cerevisiae. It is understood that any suitable microbial host organism can be used to introduce metabolic and/or genetic modifications to produce a desired product.
Examplary E. coli host organisms include any non-pathogenic E. coli strain, including E. coli strains falling within taxonomic lineages such as A, B1, and B2. E. coli K-12 strains are in subgroup A. Host organisms include derivatives and variants of E. coli K-12, such as W3110 and MG1655. See, for example, Kuhnert, P., et at. (1995) Rapid and accurate identification of Escherichia coli K-12 strains. Applied and Environmental Microbiology 61:4135-4139; Bachmann, B. J. (1972) Pedigrees of some mutant strains of Escherichia coli K-12. Bacteriol. Rev. 36 525-57; and Bachmann, B. J. Derivations and genotypes of some mutant derivatives of Escherichia coli K-12. In: Neidhardt, F. C. et al. (1996) Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology (ASM Press, Washington, D.C.)
In some embodiments, a heterologous nucleic acid encoding a pathway enzyme of the disclosure can be described as obtained from an organism (such as a bacteria) that is other than the organisms of the host group. For example, the heterologous nucleic acid can be from a bacterial organism other than an organism selected from the group consisting of E. coli, K. oxytoca, A. succiniciproducens, etc.
In particularly useful embodiments, exogenous expression of the encoding nucleic acids is employed. Exogenous expression confers the ability to custom tailor the expression and/or regulatory elements to the host and application to achieve a desired expression level that is controlled by the user. However, endogenous expression also can be utilized in other embodiments such as by removing a negative regulatory effector or induction of the gene's promoter when linked to an inducible promoter or other regulatory element. Thus, an endogenous gene having a naturally occurring inducible promoter can be up-regulated by providing the appropriate inducing agent, or the regulatory region of an endogenous gene can be engineered to incorporate an inducible regulatory element, thereby allowing the regulation of increased expression of an endogenous gene at a desired time. Similarly, an inducible promoter can be included as a regulatory element for an exogenous gene introduced into a non-naturally occurring microbial organism.
Sources of encoding nucleic acids for a butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol and/or 2,4-pentadienoate pathway enzyme or protein can include, for example, any species where the encoded gene product is capable of catalyzing the referenced reaction. Such species include both prokaryotic and eukaryotic organisms including, but not limited to, bacteria, including archaea and eubacteria, and eukaryotes, including yeast, plant, insect, animal, and mammal, including human. Exemplary species for such sources include, for example, Escherichia species, including Escherichia coli, Escherichia fergusonii, Methanocaldococcus jannaschii, Leptospira interrrogans, Geobacter sulfurreducens, Chloroflexus aurantiacus, Roseflexus sp. RS-1, Chloroflexus aggregans, Achromobacter xylosoxydans, Clostridia species, including Clostridium kluyveri, Clostridium symbiosum, Clostridium acetobutylicum, Clostridium saccharoperbutylacetonicum, Clostridium ljungdahlii, Trichomonas vaginalis G3, Trypanosoma brucei, Acidaminococcus fermentans, Fusobacterium species, including Fusobacterium nucleatum, Fusobacterium mortiferum, Corynebacterium glutamicum, Rattus norvegicus, Homo sapiens, Saccharomyces species, including Saccharomyces cerevisiae, Aspergillus species, including Aspergillus terreus, Aspergillus oryzae, Aspergillus niger, Gibberella zeae, Pichia stipitis, Mycobacterium species, including Mycobacterium smegmatis, Mycobacterium avium, including subsp. pratuberculosis, Salinispora arenicola Pseudomonas species, including Pseudomonas sp. CF600, Pseudomonas putida, Pseudomonas fluorescens, Pseudomonas aeruginosa, Ralstonia species, including Ralstonia eutropha, Ralstonia eutropha JMP134, Ralstonia eutropha H16, Ralstonia pickettii, Lactobacillus plantarum, Klebsiella oxytoca, Bacillus species, including Bacillus subtilis, Bacillus pumilus, Bacillus megaterium, Pedicoccus pentosaceus, Chlorofexus species, including Chloroflexus aurantiacus, Chloroflexus aggregans, Rhodobacter sphaeroides, Methanocaldococcus jannaschii, Leptospira interrrogans, Candida maltosa, Salmonella species, including Salmonella enterica serovar Typhimurium, Shewanella species, including Shewanella oneidensis, Shewanella sp. MR-4, Alcaligenes faecalis, Geobacillus stearothermophilus, Serratia marcescens, Vibrio cholerae, Eubacterium barkeri, Bacteroides capillosus, Archaeoglobus fulgidus, Archaeoglobus fulgidus, Haloarcula marismortui, Pyrobaculum aerophilum str. IM2, Rhizobium species, including Rhizobium leguminosarum, as well as other exemplary species disclosed herein or available as source organisms for corresponding genes. However, with the complete genome sequence available for now more than 550 species (with more than half of these available on public databases such as the NCBI), including 395 microorganism genomes and a variety of yeast, fungi, plant, and mammalian genomes, the identification of genes encoding the requisite butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate biosynthetic activity for one or more genes in related or distant species, including for example, homologues, orthologs, paralogs and nonorthologous gene displacements of known genes, and the interchange of genetic alterations between organisms is routine and well known in the art. Accordingly, the metabolic alterations allowing biosynthesis of butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate described herein with reference to a particular organism such as E. coli can be readily applied to other microorganisms, including prokaryotic and eukaryotic organisms alike. Given the teachings and guidance provided herein, those skilled in the art will know that a metabolic alteration exemplified in one organism can be applied equally to other organisms.
In some instances, such as when an alternative butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate biosynthetic pathway exists in an unrelated species butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate biosynthesis can be conferred onto the host species by, for example, exogenous expression of a paralog or paralogs from the unrelated species that catalyzes a similar, yet non-identical metabolic reaction to replace the referenced reaction. Because certain differences among metabolic networks exist between different organisms, those skilled in the art will understand that the actual gene usage between different organisms may differ. However, given the teachings and guidance provided herein, those skilled in the art also will understand that the teachings and methods of the invention can be applied to all microbial organisms using the cognate metabolic alterations to those exemplified herein to construct a microbial organism in a species of interest that will synthesize butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol and/or 2,4-pentadienoate.
Methods for constructing and testing the expression levels of a non-naturally occurring butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol and/or 2,4-pentadienoate-producing host can be performed, for example, by recombinant and detection methods well known in the art. Such methods can be found described in, for example, Sambrook et al., Molecular Cloning: A Laboratory Manual, Third Ed., Cold Spring Harbor Laboratory, New York (2001); and Ausubel et al., Current Protocols in Molecular Biology, John Wiley and Sons, Baltimore, Md. (1999).
Exogenous nucleic acid sequences involved in a pathway for production of butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol and/or 2,4-pentadienoate can be introduced stably or transiently into a host cell using techniques well known in the art including, but not limited to, conjugation, electroporation, chemical transformation, transduction, transfection, and ultrasound transformation. For exogenous expression in E. coli or other prokaryotic cells, some nucleic acid sequences in the genes or cDNAs of eukaryotic nucleic acids can encode targeting signals such as an N-terminal mitochondrial or other targeting signal, which can be removed before transformation into prokaryotic host cells, if desired. For example, removal of a mitochondrial leader sequence led to increased expression in E. coli (Hoffmeister et al., J. Biol. Chem. 280:4329-4338 (2005)). For exogenous expression in yeast or other eukaryotic cells, genes can be expressed in the cytosol without the addition of leader sequence, or can be targeted to mitochondrion or other organelles, or targeted for secretion, by the addition of a suitable targeting sequence such as a mitochondrial targeting or secretion signal suitable for the host cells. Thus, it is understood that appropriate modifications to a nucleic acid sequence to remove or include a targeting sequence can be incorporated into an exogenous nucleic acid sequence to impart desirable properties. Furthermore, genes can be subjected to codon optimization with techniques well known in the art to achieve optimized expression of the proteins.
An expression vector or vectors can be constructed to include one or more butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate biosynthetic pathway encoding nucleic acids as exemplified herein operably linked to expression control sequences functional in the host organism. Expression vectors applicable for use in the microbial host organisms of the invention include, for example, plasmids, phage vectors, viral vectors, episomes and artificial chromosomes, including vectors and selection sequences or markers operable for stable integration into a host chromosome. Additionally, the expression vectors can include one or more selectable marker genes and appropriate expression control sequences. Selectable marker genes also can be included that, for example, provide resistance to antibiotics or toxins, complement auxotrophic deficiencies, or supply critical nutrients not in the culture media. Expression control sequences can include constitutive and inducible promoters, transcription enhancers, transcription terminators, and the like which are well known in the art. When two or more exogenous encoding nucleic acids are to be co-expressed, both nucleic acids can be inserted, for example, into a single expression vector or in separate expression vectors. For single vector expression, the encoding nucleic acids can be operationally linked to one common expression control sequence or linked to different expression control sequences, such as one inducible promoter and one constitutive promoter. The transformation of exogenous nucleic acid sequences involved in a metabolic or synthetic pathway can be confirmed using methods well known in the art. Such methods include, for example, nucleic acid analysis such as Northern blots or polymerase chain reaction (PCR) amplification of mRNA, or immunoblotting for expression of gene products, or other suitable analytical methods to test the expression of an introduced nucleic acid sequence or its corresponding gene product. It is understood by those skilled in the art that the exogenous nucleic acid is expressed in a sufficient amount to produce the desired product, and it is further understood that expression levels can be optimized to obtain sufficient expression using methods well known in the art and as disclosed herein.
The invention additionally provides methods of producing butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate using the microbial organisms of the invention comprising one or more pathway gene(s). In a particular embodiment, the invention provides a method for producing a target compound by culturing a non-naturally occurring microbial organism, comprising a microbial organism having a butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate pathway comprising at least one exogenous nucleic acid encoding a pathway enzyme expressed in a sufficient amount to produce butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate, under conditions and for a sufficient period of time.
Suitable purification and/or assays to test for the production of producing butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate can be performed using well known methods. Suitable replicates such as triplicate cultures can be grown for each engineered strain to be tested. For example, product and byproduct formation in the engineered production host can be monitored. The final product and intermediates, and other organic compounds, can be analyzed by methods such as HPLC (High Performance Liquid Chromatography), GC-MS (Gas Chromatography-Mass Spectroscopy) and LC-MS (Liquid Chromatography-Mass Spectroscopy) or other suitable analytical methods using routine procedures well known in the art. The release of product in the fermentation broth can also be tested with the culture supernatant. Byproducts and residual glucose can be quantified by HPLC using, for example, a refractive index detector for glucose and alcohols, and a UV detector for organic acids (Lin et al., Biotechnol. Bioeng. 90:775-779 (2005)), or other suitable assay and detection methods well known in the art. The individual enzyme or protein activities from the exogenous DNA sequences can also be assayed using methods well known in the art.
The butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate can be separated from other components in the culture using a variety of methods well known in the art. Such separation methods include, for example, extraction procedures as well as methods that include continuous liquid-liquid extraction, pervaporation, membrane filtration, membrane separation, reverse osmosis, electrodialysis, distillation, crystallization, centrifugation, extractive filtration, ion exchange chromatography, size exclusion chromatography, adsorption chromatography, and ultrafiltration. All of the above methods are well known in the art.
Any of the non-naturally occurring microbial organisms described herein can be cultured to produce and/or secrete the biosynthetic products of the invention. For example, the butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate producers can be cultured for the biosynthetic production of butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate.
For the production of butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate, the recombinant strains are cultured in a medium with carbon source and other essential nutrients. It is sometimes desirable and can be highly desirable to maintain anaerobic conditions in the fermenter to reduce the cost of the overall process. Such conditions can be obtained, for example, by first sparging the medium with nitrogen and then sealing the flasks with a septum and crimp-cap. For strains where growth is not observed anaerobically, microaerobic or substantially anaerobic conditions can be applied by perforating the septum with a small hole for limited aeration. Exemplary anaerobic conditions have been described previously and are well-known in the art. Exemplary aerobic and anaerobic conditions are described, for example, in United State publication 2009/0047719, filed Aug. 10, 2007. Fermentations can be performed in a batch, fed-batch or continuous manner, as disclosed herein.
If desired, the pH of the medium can be maintained at a desired pH, in particular neutral pH, such as a pH of around 7 by addition of a base, such as NaOH or other bases, or acid, as needed to maintain the culture medium at a desirable pH. The growth rate can be determined by measuring optical density using a spectrophotometer (600 nm), and the glucose uptake rate by monitoring carbon source depletion over time.
The growth medium can include, for example, any carbohydrate source which can supply a source of carbon to the non-naturally occurring microorganism. Such sources include, for example, sugars such as glucose, xylose, arabinose, galactose, mannose, fructose, sucrose and starch. Other sources of carbohydrate include, for example, renewable feedstocks and biomass. Exemplary types of biomasses that can be used as feedstocks in the methods of the invention include cellulosic biomass, hemicellulosic biomass and lignin feedstocks or portions of feedstocks. Such biomass feedstocks contain, for example, carbohydrate substrates useful as carbon sources such as glucose, xylose, arabinose, galactose, mannose, fructose and starch. Other non-carbohydrate feedstocks include alcohols such as methanol, ethanol and glycerol and gaseous carbon substrates such as methane and syngas. Given the teachings and guidance provided herein, those skilled in the art will understand that renewable feedstocks and biomass other than those exemplified above also can be used for culturing the microbial organisms of the invention for the production of butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate.
In some embodiments, culture conditions include anaerobic or substantially anaerobic growth or maintenance conditions. Exemplary anaerobic conditions have been described previously and are well known in the art. Exemplary anaerobic conditions for fermentation processes are described herein and are described, for example, in U.S. publication 2009/0047719, filed Aug. 10, 2007. Any of these conditions can be employed with the non-naturally occurring microbial organisms as well as other anaerobic conditions well known in the art. Under such anaerobic or substantially anaerobic conditions, butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate producers can synthesize butadiene, crotyl alcohol, 3-buten-1-ol, 3-buten-2-ol, and/or 2,4-pentadienoate at intracellular concentrations of 5-10 mM or more as well as all other concentrations exemplified herein. It is understood that, even though the above description refers to intracellular concentrations, butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate producing microbial organisms can butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate intracellularly and/or secrete the product into the culture medium.
In addition to the culturing and fermentation conditions disclosed herein, growth condition for achieving biosynthesis of butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate can include the addition of an osmoprotectant to the culturing conditions. In certain embodiments, the non-naturally occurring microbial organisms of the invention can be sustained, cultured or fermented as described herein in the presence of an osmoprotectant. Briefly, an osmoprotectant refers to a compound that acts as an osmolyte and helps a microbial organism as described herein survive osmotic stress. Osmoprotectants include, but are not limited to, betaines, amino acids, and the sugar trehalose. Non-limiting examples of such are glycine betaine, proline betaine, dimethylthetin, dimethylsulfoniopropionate, 3-dimethylsulfonio-2-methylpropionate, pipecolic acid, dimethylsulfonioacetate, choline, L-carnitine and ectoine. In one aspect, the osmoprotectant is glycine betaine.
In some embodiments, the carbon feedstock and other cellular uptake sources such as phosphate, ammonia, sulfate, chloride and other halogens can be chosen to alter the isotopic distribution of the atoms present in butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate or any pathway intermediate. The various carbon feedstock and other uptake sources enumerated above will be referred to herein, collectively, as “uptake sources.”
As used herein, the term “bioderived” means derived from or synthesized by a biological organism and can be considered a renewable resource since it can be generated by a biological organism. Such a biological organism, in particular the microbial organisms of the invention disclosed herein, can utilize feedstock or biomass, such as, sugars or carbohydrates obtained from an agricultural, plant, bacterial, or animal source. Alternatively, the biological organism can utilize atmospheric carbon. As used herein, the term “biobased” means a product as described above that is composed, in whole or in part, of a bioderived compound of the invention. A biobased or bioderived product is in contrast to a petroleum derived product, wherein such a product is derived from or synthesized from petroleum or a petrochemical feedstock.
The culture conditions can include, for example, liquid culture procedures as well as fermentation and other large scale culture procedures. As described herein, particularly useful yields of the biosynthetic products of the invention can be obtained under anaerobic or substantially anaerobic culture conditions.
As described herein, one exemplary growth condition for achieving biosynthesis of butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate includes anaerobic culture or fermentation conditions. In certain embodiments, the non-naturally occurring microbial organisms of the invention can be sustained, cultured or fermented under anaerobic or substantially anaerobic conditions. Anaerobic conditions refer to an environment devoid of oxygen.
The culture conditions described herein can be scaled up and grown continuously for manufacturing of butadiene, crotyl alcohol, 3-buten-2-ol, 3-buten-1-ol, and/or 2,4-pentadienoate. Exemplary growth procedures include, for example, fed-batch fermentation and batch separation; fed-batch fermentation and continuous separation, or continuous fermentation and continuous separation.
Several pathways are shown in
In
Pathways converting lactoyl-CoA to 4-hydroxypent-2-enoate, and further to 3-buten-2-ol and butadiene, are shown in
The enzyme activities required for the reactions shown in
Escherichia coli
Escherichia coli
Saccharomyces
cerevisiae
Saccharomyces
cerevisiae
Saccharomyces
cerevisiae
Kluyveromyces
lactis NRRL
Yarrowia lipolytica
Candida tropicalis
Ralstonia eutropha
Clostridium
beijerinckii
Thermo-
anaerobacter
brockii HTD4
Rhodococcus ruber
Pyrococcus furiosus
Pseudomonas fragi
Ralstonia pickettii
Ralstonia pickettii
Ralstonia pickettii
Homo sapiens
Candida
parapsilosis
Alcohol dehydrogenases that reduce 3-ketoacids to their corresponding 3-hydroxyacids, required for the reduction of 3-oxo-4-hydroxypentanoate (3C), have also been characterized. These enzymes include 3-hydroxybutyrate dehydrogenase (EC 1.1.1.30), 3-hydroxyisobutyrate dehydrogenase (EC 1.1.1.31), threonine dehydrogenase (EC 1.1.1.103), 3-hydroxypropionate dehydrogenase (EC 1.1.1.298) and benzyl-2-methyl-3-hydroxybutanoate dehydrogenase (EC 1.1.1.217). Recombinant 3-ketoacid reductase enzymes with broad substrate range and high activity have been characterized in US Application 2011/0201072, and are incorporated by reference herein. The mitochondrial 3-hydroxybutyrate dehydrogenase (bdh) from the human heart which has been cloned and characterized (Marks et al., J. Biol. Chem. 267:15459-15463 (1992)). Secondary alcohol dehydrogenases described above are also suitable here.
Homo sapiens
Alcohol dehydrogenase enzymes active on allyl alcohols are suitable for reducing crotyl aldehyde to crotyl alcohol (1J). Crotyl aldehyde reductase activity has been demonstrated by mdr of Synechocystis sp. PCC 6803 (Shimakawa et al, Biosci Biotechnol Biochem 77:2441-8 (2013)). An exemplary allyl alcohol dehydrogenase is the NtRed-1 enzyme from Nicotiana tabacum (Matsushima et al, Bioorg Chem 36: 23-8 (2008)). A similar enzyme has been characterized in Pseudomonas putida MB 1 but the enzyme has not been associated with a gene to date (Malone et al, AEM 65: 2622-30 (1999)). Yet another allyl alcohol dehydrogenase is the geraniol dehydrogenase enzymes of Castellaniella defragrans, Carpoglyphus lactis and Ocimum basilicum (Lueddeke et al, AEM 78:2128-36 (2012)). Alcohol dehydrogenase enzymes with broad substrate specificity are also applicable here, such as include alrA encoding a medium-chain alcohol dehydrogenase for C2-C14 (Tani et al., Appl. Environ. Microbiol. 66:5231-5235 (2000)), yqhD, yahK, adhE and fucO from E. coli (Sulzenbacher et al., J Mol Biol 342:489-502 (2004)), and bdh I and bdh II from C. acetobutylicum which converts butyryaldehyde into butanol (Walter et al, J. Bacteriol 174:7149-7158 (1992)). YqhD of E. coli catalyzes the reduction of a wide range of aldehydes using NADPH as the cofactor, with a preference for chain lengths longer than C(3) (Sulzenbacher et al, J Mol Biol 342:489-502 (2004); Perez et al., J Biol. Chem. 283:7346-7353 (2008)). The adhA gene product from Zymomonas mobilis has been demonstrated to have activity on a number of aldehydes including formaldehyde, acetaldehyde, propionaldehyde, butyraldehyde, and acrolein (Kinoshita et al., Appl Microbiol Biotechnol 22:249-254 (1985)).
Synechocystis sp. PCC 6803
Nicotiana tabacum
Castellaniella defragrans
Ocimum basilicum
Carpoglyphus lactis
Acinetobacter sp. strain M-1
Saccharomyces cerevisiae
Escherichia coli
Escherichia coli
Escherichia coli
Escherichia coli
Clostridium acetobutylicum
Clostridium acetobutylicum
Zymomonas mobilis
Clostridium
saccharoperbutylacetonicum
Alcohol dehydrogenases active on 3-hydroxyacyl-CoA and 2-hydroxyacyl-CoA substrates catalyze the reduction of 2-oxopent-3-enoyl-CoA (
Escherichia coli
Escherichia coli
Escherichia coli
Clostridium kluyveri
Clostridium kluyveri
Pseudomonas putida
Pseudomonas
fluorescens
Bos taurus
Zoogloea ramigera
Rhodobacter sphaeroides
Paracoccus denitrificans
Clostridium
acetobutylicum
Clostridium beijerinckii
Bos taurus
Acetyl-CoA reductase (an acyl-CoA reductase in EC class 1.2.1.-) catalyzes the reduction of acetyl-CoA to acetaldehyde. Several acyl-CoA dehydrogenases reduce an acyl-CoA to its corresponding aldehyde and represent suitable enzyme candidates for catalyzing step A of
Escherichia coli
Escherichia coli
Pseudomonas sp. CF600
Clostridium acetobutylicum
Clostridium acetobutylicum
Clostridium beijerinckii
Escherichia coli
Salmonella typhimurium
Pseudomonas sp
Leuconostoc mesenteroides
Clostridium
saccharoperbutylacetonicum
Pseudomonas sp. CF600
Pseudomonas sp. CF600
Burkholderia xenovorans
Burkholderia xenovorans
Beta-ketothiolase enzymes are required for the conversion of lactoyl-CoA and acetyl-CoA to 3-oxo-4-hydroxypentanoyl-CoA, shown in
Ralstonia eutropha
Ralstonia eutropha
Ralstonia eutropha
Ralstonia eutropha
Ralstonia eutropha
Ralstonia eutropha
Ralstonia eutropha
Ralstonia eutropha
Ralstonia eutropha
Ralstonia eutropha
Ralstonia eutropha
Ralstonia eutropha
Ralstonia eutropha
Zoogloea ramigera
Cupriavidus taiwanensis
Ralstonia metallidurans
Burkholderia phymatum
Escherichia coli
Clostridium
acetobutylicum
Clostridium
acetobutylicum
Saccharomyces
cerevisiae
Pseudomonas putida
Acinetobacter
calcoaceticus
Pseudomonas
knackmussii
CrotOH kinase enzymes catalyze the transfer of a phosphate group to the hydroxyl group of CrotOH, shown in step A of
Mevalonate kinase (EC 2.7.1.36) phosphorylates the terminal hydroxyl group of mevalonate. Gene candidates for this step include erg12 from S. cerevisiae, mvk from Methanocaldococcus jannaschi, MVK from Homo sapeins, and mvk from Arabidopsis thaliana col. Additional mevalonate kinase candidates include the feedback-resistant mevalonate kinase from the archeon Methanosarcina mazei (Primak et al, AEM, in press (2011)) and the Mvk protein from Streptococcus pneumoniae (Andreassi et al, Protein Sci, 16:983-9 (2007)). Mvk proteins from S. cerevisiae, S. pneumoniae and M. mazei were heterologously expressed and characterized in E. coli (Primak et al, supra). The S. pneumoniae mevalonate kinase was active on several alternate substrates including cylopropylmevalonate, vinylmevalonate and ethynylmevalonate (Kudoh et al, Bioorg Med Chem 18:1124-34 (2010)), and a subsequent study determined that the ligand binding site is selective for compact, electron-rich C(3)-substituents (Lefurgy et al, J Biol Chem 285:20654-63 (2010)).
Sachharomyces cerevisiae
Methanocaldococcus jannaschii
Homo sapiens
Arabidopsis thaliana
Methanosarcina mazei
Streptococcus pneumoniae
Glycerol kinase also phosphorylates the terminal hydroxyl group in glycerol to form glycerol-3-phosphate. This reaction occurs in several species, including Escherichia coli, Saccharomyces cerevisiae, and Thermotoga maritima. The E. coli glycerol kinase has been shown to accept alternate substrates such as dihydroxyacetone and glyceraldehyde (Hayashi et al., J Biol. Chem. 242:1030-1035 (1967)). T, maritime has two glycerol kinases (Nelson et al., Nature 399:323-329 (1999)). Glycerol kinases have been shown to have a wide range of substrate specificity. Crans and Whiteside studied glycerol kinases from four different organisms (Escherichia coli, S. cerevisiae, Bacillus stearothermophilus, and Candida mycoderma) (Crans et al., J. Am. Chem. Soc. 107:7008-7018 (2010); Nelson et al., supra, (1999)). They studied 66 different analogs of glycerol and concluded that the enzyme could accept a range of substituents in place of one terminal hydroxyl group and that the hydrogen atom at C2 could be replaced by a methyl group. Interestingly, the kinetic constants of the enzyme from all four organisms were very similar.
Escherichia coli K12
Thermotoga maritime MSB8
Thermotoga maritime MSB8
Saccharomyces cerevisiae
Homoserine kinase is another possible candidate. This enzyme is also present in a number of organisms including E. coli, Streptomyces sp, and S. cerevisiae. Homoserine kinase from E. coli has been shown to have activity on numerous substrates, including, L-2-amino,1,4-butanediol, aspartate semialdehyde, and 2-amino-5-hydroxyvalerate (Huo et al., Biochemistry 35:16180-16185 (1996); Huo et al., Arch. Biochem. Biophys. 330:373-379 (1996)). This enzyme can act on substrates where the carboxyl group at the alpha position has been replaced by an ester or by a hydroxymethyl group.
Escherichia
coli K12
Streptomyces
Saccharomyces
serevisiae
Other classes of kinases that can catalyze the phosphorylation of crotyl alcohol are hydroxyethylthiazole kinase, thiamine kinase, pantothenate kinase, 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase, riboflavin kinase, L-fuculokinase and choline kinase. Exemplary gene candidates for each of these classes are shown below.
The table below provides gene candidates for hydroxyethyl thiazole kinases
Bacillus subtilis
Saccharomyces
serevisiae
Staphylococcus aureus
Pyrococcus horikoshii
Enterococcus faecalis
Streptococcus
pneumoniae SPNA45
Lactobacillus
plantarum WCFS1
Citrobacter rodentium
Salmonella enterica
Rhizobium
leguminosarum bv.
viciae 3841
Escherichia coli str.
Some candidate thiamine kinases are:
Escherichia coli K12
Salmonella enterica subsp.
enterica serovar
Typhimurium str. LT2
Examplary fuculokinases are:
Escherichia coli K12
Salmonella enterica subsp.
enterica serovar
Typhimurium str.
Citrobacter freundii ATCC
6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase can also carry the described transformation. Gene candidates from this class are listed below.
Escherichia coli K12
Enterococcus faecalis V583
Pantothenate kinases that can catalyze the transformation are:
Mycobacterium
tuberculosis H37Rv
Escherichia coli K12
Thermotoga maritima
Staphylococcus aureus
Yet another candidate enzyme class of interest is 4-(cytidine 5′-diphospho)-2-C-methyl-D-erythritol kinase (2.7.1.148). Gene candidates from this class are:
Escherichia coli K12
Mycobacterium tuberculosis
2-Butenyl-4-phosphate kinase enzymes catalyze the transfer of a phosphate group to the phosphate group of 2-butenyl-4-phosphate (
Phosphomevalonate kinase enzymes are of particular interest. Phosphomevalonate kinase (EC 2.7.4.2) catalyzes the analogous transformation to 2-butenyl-4-phosphate kinase. This enzyme is encoded by erg8 in Saccharomyces cerevisiae (Tsay et al., Mol. Cell Biol. 11:620-631 (1991)) and mvaK2 in Streptococcus pneumoniae, Staphylococcus aureus and Enterococcus faecalis (Doun et al., Protein Sci. 14:1134-1139 (2005); Wilding et al., J Bacteriol. 182:4319-4327 (2000)). The Streptococcus pneumoniae and Enterococcus faecalis enzymes were cloned and characterized in E. coli (Pilloff et al., J Biol. Chem. 278:4510-4515 (2003); Doun et al., Protein Sci. 14:1134-1139 (2005)). The S. pneumoniae phosphomevalonate kinase was active on several alternate substrates including cylopropylmevalonate phosphate, vinylmevalonate phosphate and ethynylmevalonate phosphate (Kudoh et al, Bioorg Med Chem 18:1124-34 (2010)). These and related enzymes are shown in the table below.
Saccharomyces cerevisiae
Staphylococcus aureus
Streptococcus pneumoniae
Enterococcus faecalis
Carnobacterium sp. WN1359
Lactobacillus plantarum WCFS1
Streptomyces sp. KO-3988
Nocardia brasiliensis ATCC
Corynebacteriurn terpenotabidum
Methanocaldococcus jannaschii
Thermoplasma acidophilum DSM
Methanothermobacter
thermautotrophicus
Methanocella paludicola SANAE
Methanosarcina barkeri Fusaro
Candidatus Methanomethylophilus
Methanobacterium
thermoautotrophicum
Haloferax volcanii
Additional kinase enzymes include fosfomycin kinase (FomA) which is highly homologous to isopentenyl phosphate kinase and is an antibiotic resistance enzyme found in a few strains of Streptomyces and Pseudomonas (Mabangalo et al. Biochemistry 51(4):917-925 (2012)). Superposition of Thermoplasma acidophilum (THA) IPK and FomA structures aligns their respective substrates and catalytic residues. These residues are conserved only in the IPK and FomA members of the phosphate subdivision of the amino acid kinase superfamily. IPK from Thermoplasma acidophilum has been shown to have activity on fosmomycin. An exemplary fosfomycin kinase is that from Streptomyces wedmorensis, Genbank ID BAA32493.1 and GI number 3452580.
Farnesyl monophosphate kinase enzymes catalyze the CTP dependent phosphorylation of farnesyl monophosphate to famesyl diphosphate. Similarly, geranylgeranyl phosphate kinase catalyzes CTP dependent phosphorylation. Enzymes with these activities were identified in the microsomal fraction of cultured Nicotiana tabacum (Thai et al, PNAS 96:13080-5 (1999)). However, the associated genes have not been identified to date.
Additional enzymes include those of the EC 2.7.2.8 class. This class is exemplified by acetylglutamate kinase, including the exemplary enzymes below:
Pyrococcus abyssi GE5
Pyrococcus furiosus DSM
Archaeoglobus fulgidus
CrotOH diphosphokinase enzymes catalyze the transfer of a diphosphate group to the hydroxyl group of CrotOH, shown in step I of
Of particular interest are ribose-phosphate diphosphokinase enzymes which have been identified in Escherichia coli (Hove-Jenson et al., J Biol Chem, 1986, 261(15); 6765-71) and Mycoplasma pneumoniae M129 (McElwain et al, International Journal of Systematic Bacteriology, 1988, 38:417-423) as well as thiamine diphosphokinase enzymes. Exemplary thiamine diphosphokinase enzymes are found in Arabidopsis thaliana (Ajjawi, Plant Mol Biol, 2007, 65(1-2); 151-62).
Escherichia coli
Mycoplasma pneumoniae M129
Arabidopsis thaliana col
Arabidopsis thaliana col
Olefin-forming decarboxylase enzymes suitable for converting 3-hydroxypent-4-enoate to butadiene (Step K of
Saccharomyces cerevisiae
Homo sapiens
Staphylococcus aureus
Trypsonoma brucei
The condensation of pyruvate and acetaldehyde to 4-hydroxy-2-oxovalerate (Step B of
Escherichia coli
Pseudomonas putida
Pseudomonas putida
Pseudomonas sp. CF600
Pseudomonas sp. CF600
Burkholderia xenovorans
Burkholderia xenovorans
Butadiene Synthase (BDS), shown in Step C of
Particularly useful enzymes include isoprene synthase, myrcene synthase and farnesene synthase. Enzyme candidates are described below, and in the enzymes and classes for
Isoprene synthase naturally catalyzes the conversion of dimethylallyl diphosphate to isoprene, but can also catalyze the synthesis of 1,3-butadiene from 2-butenyl-4-diphosphate. Isoprene synthases can be found in several organisms including Populus alba (Sasaki et al., FEBS Letters, 2005, 579 (11), 2514-2518), Pueraria montana (Lindberg et al., Metabolic Eng, 12(1):70-79 (2010); Sharkey et al., Plant Physiol., 137(2):700-712 (2005)), and Populus tremula×Populus alba, also called Populus canescens (Miller et al., Planta, 2001, 213 (3), 483-487). The crystal structure of the Populus canescens isoprene synthase was determined (Koksal et al, J Mol Biol 402:363-373 (2010)). Additional isoprene synthase enzymes are described in (Chotani et al., WO/2010/031079, Systems Using Cell Culture for Production of Isoprene; Cervin et al., US Patent Application 20100003716, Isoprene Synthase Variants for Improved Microbial Production of Isoprene).
Populus alba
Pueraria montana
Populus tremula x Populus alba
Myrcene synthase enzymes catalyze the dephosphorylation of geranyl diphosphate to beta-myrcene (EC 4.2.3.15). Exemplary myrcene synthases are encoded by MST2 of Solanum lycopersicum (van Schie et al, Plant Mol Biol 64:D473-79 (2007)), TPS-Myr of Picea abies (Martin et al, Plant Physiol 135:1908-27 (2004)) g-myr of Abies grandis (Bohlmann et al, J Biol Chem 272:21784-92 (1997)) and TPS10 of Arabidopsis thaliana (Bohlmann et al, Arch Biochem Biophys 375:261-9 (2000)). These enzymes were heterologously expressed in E. coli.
Solanum lycopersicum
Picea abies
Abies grandis
Arabidopsis thaliana
Famesyl diphosphate is converted to alpha-farnesene and beta-farnesene by alpha-farnesene synthase and beta-farnesene synthase, respectively. Exemplary alpha-farnesene synthase enzymes include TPS03 and TPS02 of Arabidopsis thaliana (Faldt et al, Planta 216:745-51 (2003); Huang et al, Plant Physiol 153:1293-310 (2010)), afs of Cucumis sativus (Mercke et al, Plant Physiol 135:2012-14 (2004), eafar of Malus×domestica (Green et al, Phytochem 68:176-88 (2007)) and TPS-Far of Picea abies (Martin, supra). An exemplary beta-farnesene synthase enzyme is encoded by TPS1 of Zea mays (Schnee et al, Plant Physiol 130:2049-60 (2002)).
Arabidopsis thaliana
Arabidopsis thaliana
Picea abies
Cucumis sativus
Malus x domestica
Zea mays
The activation of pathway intermediates such as 2-oxopent-3-enoate (1N), 2-hydroxypent-3-enoate (1R), 5-hydroxypent-4-enoate (2I), 2,4-pentadienoate (2J), 3-hydroxypent-4-enoate (2L) can be catalyzed by ADP and AMP-forming CoA ligases (6.2.1). These enzymes can also function in the reverse direction to convert the CoA-derivatives to their acid counterparts as shown in Steps 1Q, 3B, 3I, 3J and 3N.
Several enzymes with broad substrate specificities have been described in the literature. The ADP-forming acetyl-CoA synthetase (ACD, EC 6.2.1.13) from Archaeoglobus fulgidus, encoded by AF1211, was shown to operate on a variety of linear and branched-chain substrates including isobutyrate, isopentanoate, and fumarate (Musfeldt et al., J Bacteriol. 184:636-644 (2002)). A second reversible ACD in Archaeoglobus fulgidus, encoded by AF1983, was also indicated to have a broad substrate range (Musfeldt et al., supra). The enzyme from Haloarcula marismortui, annotated as a succinyl-CoA synthetase, accepts propionate, butyrate, and branched-chain acids (isovalerate and isobutyrate) as substrates, and was shown to operate in the forward and reverse directions (Brasen et al., Arch. Microbiol 182:277-287 (2004)). The ACD encoded by PAE3250 from hyperthermophilic crenarchaeon Pyrobaculum aerophilum showed the broadest substrate range of all characterized ACDs, reacting with acetyl-CoA, isobutyryl-CoA (preferred substrate) and phenylacetyl-CoA (Brasen and Schonheit, J Arch. Microbiol 182:277-287 (2004)). Directed evolution or engineering can be used to modify this enzyme to operate at the physiological temperature of the host organism. The enzymes from A. fulgidus, H. marismortui and P. aerophilum have all been cloned, functionally expressed, and characterized in E. coli (Brasen and Schonheit, Arch. Microbiol 182:277-287 (2004); Musfeldt and Schonheit, J Bacteriol. 184:636-644 (2002)). An additional enzyme is encoded by sucCD in E. coli, which naturally catalyzes the formation of succinyl-CoA from succinate with the concomitant consumption of one ATP, a reaction which is reversible in vivo (Buck et al., Biochemistry 24:6245-6252 (1985)). The acyl CoA ligase from Pseudomonas putida has been indicated to work on several aliphatic substrates including acetic, propionic, butyric, valeric, hexanoic, heptanoic, and octanoic acids and on aromatic compounds such as phenylacetic and phenoxyacetic acids (Femandez-Valverde et al., Appl. Environ. Microbiol. 59:1149-1154 (1993)). A related enzyme, malonyl CoA synthetase (6.3.4.9) from Rhizobium leguminosarum could convert several diacids, namely, ethyl-, propyl-, allyl-, isopropyl-, dimethyl-, cyclopropyl-, cyclopropylmethylene-, cyclobutyl-, and benzyl-malonate into their corresponding monothioesters (Pohl et al., J. Am. Chem. Soc. 123:5822-5823 (2001)). Recently, a CoA dependent acetyl-CoA ligase was also identified in Propionibacterium acidipropionici ATCC 4875 (Parizzi et al., BMC Genomics. 2012; 13: 562., The genome sequence of Propionibacterium acidipropionici provides insights into its biotechnological and industrial potential). This enzyme is distinct from the AMP-dependent acetyl-CoA synthetase and is instead related to the ADP-forming succinyl-CoA synthetase complex (SCSC). Genes releted to the SCSC (α and β subunits) complex were also found in Propionibacterium acnes KPA171202 and Microlunatus phophovorus NM-1.
The acylation of acetate to acetyl-CoA is catalyzed by enzymes with acetyl-CoA synthetase activity. Two enzymes that catalyze this reaction are AMP-forming acetyl-CoA synthetase (EC 6.2.1.1) and ADP-forming acetyl-CoA synthetase (EC 6.2.1.13). AMP-forming acetyl-CoA synthetase (ACS) is the predominant enzyme for activation of acetate to acetyl-CoA. Exemplary ACS enzymes are found in E. coli (Brown et al., J. Gen. Microbiol 102:327-336 (1977)), Ralstonia eutropha (Priefert et al., 174:6590-6599 (1992)), Methanothermobacter thermautotrophicus (Ingram-Smith et al., Archaea. 2:95-107 (2007)), Salmonella enterica (Gulick et al., 42:2866-2873 (2003)) and Saccharomyces cerevisiae (Jogl et al., 43:1425-1431 (2004)).
Methylmalonyl-CoA synthetase from Rhodopseudomonas palustris (MatB) converts methylmalonate and malonate to methylmalonyl-CoA and malonyl-CoA, respectively. Structure-based mutagenesis of this enzyme improved CoA synthetase activity with the alternate substrates ethylmnalonate and butylmalonate (Crosby et al, AEM, in press (2012)).
Archaeoglobus
fulgidus
Archaeoglobus
fulgidus
Haloarcula
marismortui
Pyrobaculum
aerophilum str. IM2
Escherichia coli
Escherichia coli
Pseudomonas putida
Rhizobium
leguminosarum
Escherichia coli
Ralstonia eutropha
Methanothermobacter
thermautotrophicus
Salmonella enterica
Saccharomyces
cerevisiae
Saccharomyces
cerevisiae
Saccharomyces
cerevisiae
Bacillus subtilis
Pseudomonas
mendocina
Bacillus sphaericus
Penicillium
chrysogenum
Penicillium
chrysogenum
Pseudomonas putida
Propionibacterium
acidipropionici
Propionibacterium
acnes KPA171202
Propionibacterium
acnes KPA171202
Microlunatus
phosphovorus NM-1
Microlunatus
phosphovorus NM-1
Mus musculus
Homo sapiens
4HB-CoA synthetase catalyzes the ATP-dependent conversion of 4-hydroxybutyrate to 4-hydroxybutyryl-CoA. AMP-forming 4-HB-CoA synthetase enzymes are found in organisms that assimilate carbon via the dicarboxylate/hydroxybutyrate cycle or the 3-hydroxypropionate/4-hydroxybutyrate cycle. Enzymes with this activity have been characterized in Thermoproteus neutrophilus and Metallosphaera sedula (Ramos-Vera et al, J Bacteriol 192:5329-40 (2010); Berg et al, Science 318:1782-6 (2007)). Others can be inferred by sequence homology.
Thermoproteus
neutrophilus
Chloroflexus aurantiacus
Chloroflexus aggregans
Hydrogenobacter
thermophilus TK-6
Pyrobaculum islandicum
Metallosphaera sedula
CoA hydrolysis as described in Steps 1Q, 2J and 2I can be catalyzed by CoA hydrolases or thioesterases in the EC class 3.1.2. Additionally, intermediates such as 3-oxo-4-hydroxypentanoyl-CoA, 3,4-dihydroxypentanoyl-CoA, 4-hydroxypent-2-enoyl-COA, 2,4-pentadienoyl-CoA can be converted into their acid counterparts via these enzymes as shown in steps 3B, 3I, 3J, 3N respectively. Several CoA hydrolases with broad substrate ranges are suitable enzymes for hydrolyzing these intermediates. For example, the enzyme encoded by acot12 from Rattus norvegicus brain (Robinson et al., Biochem. Biophys. Res. Commun. 71:959-965 (1976)) can react with butyryl-CoA, hexanoyl-CoA and malonyl-CoA. The human dicarboxylic acid thioesterase, encoded by acot8, exhibits activity on glutaryl-CoA, adipyl-CoA, suberyl-CoA, sebacyl-CoA, and dodecanedioyl-CoA (Westin et al., J. Biol. Chem. 280:38125-38132 (2005)). The closest E. coli homolog to this enzyme, tesB, can also hydrolyze a range of CoA thiolesters (Naggert et al., J Biol Chem 266:11044-11050 (1991)). A similar enzyme has also been characterized in the rat liver (Deana R., Biochem Int 26:767-773 (1992)). Additional enzymes with hydrolase activity in E. coli include ybgC, paaI, yciA, and ybdB (Kuznetsova, et al., FEMS Microbiol Rev, 2005, 29(2):263-279; Song et al., J Biol Chem, 2006, 281(16):11028-38). Though its sequence has not been reported, the enzyme from the mitochondrion of the pea leaf has a broad substrate specificity, with demonstrated activity on acetyl-CoA, propionyl-CoA, butyryl-CoA, palmitoyl-CoA, oleoyl-CoA, succinyl-CoA, and crotonyl-CoA (Zeiher et al., Plant. Physiol. 94:20-27 (1990)) The acetyl-CoA hydrolase, ACH1, from S. cerevisiae represents another candidate hydrolase (Buu et al., J. Biol. Chem. 278:17203-17209 (2003)).
Rattus norvegicus
Escherichia coli
Homo sapiens
Rattus norvegicus
Escherichia coli
Escherichia coli
Escherichia coli
Escherichia coli
Saccharomyces cerevisiae
Escherichia coli
Escherichia coli
Escherichia coli
Yet another candidate hydrolase is the glutaconate CoA-transferase from Acidaminococcus fermentans. This enzyme was transformed by site-directed mutagenesis into an acyl-CoA hydrolase with activity on glutaryl-CoA, acetyl-CoA and 3-butenoyl-CoA (Mack et al., FEBS. Lett. 405:209-212 (1997)). This suggests that the enzymes encoding succinyl-CoA:3-ketoacid-CoA transferases and acetoacetyl-CoA:acetyl-CoA transferases may also serve as candidates for this reaction step but would require certain mutations to change their function.
Acidaminococcus fermentans
Acidaminococcus fermentans
Additional hydrolase enzymes include 3-hydroxyisobutyryl-CoA hydrolase which has been described to efficiently catalyze the conversion of 3-hydroxyisobutyryl-CoA to 3-hydroxyisobutyrate during valine degradation (Shimomura et al., J Biol Chem. 269:14248-14253 (1994)). Genes encoding this enzyme include hibch of Rattus norvegicus (Shimomura et al., Methods Enzymol. 324:229-240 (2000)) and Homo sapiens (Shimomura et al., supra). Similar gene candidates can also be identified by sequence homology, including hibch of Saccharomyces cerevisiae and BC_2292 of Bacillus cereus.
Rattus norvegicus
Homo sapiens
Saccharomyces cerevisiae
Bacillus cereus
Methylmalonyl-CoA is converted to methylmalonate by methylmalonyl-CoA hydrolase (EC 3.1.2.7). This enzyme, isolated from Rattus norvegicus liver, is also active on malonyl-CoA and propionyl-CoA as alternative substrates (Kovachy et al., J. Biol. Chem., 258: 11415-11421 (1983)). The gene associated with this enzyme is not known.
Several transformations outlined in
CoA transferase enzymes have been described in the open literature and represent suitable candidates for these steps. These are described below. The gene products of cat1, cat2, and cat3 of Clostridium kluyveri have been shown to exhibit succinyl-CoA, 4-hydroxybutyryl-CoA, and butyryl-CoA transferase activity, respectively (Seedorf et al., Proc. Natl. Acad. Sci U.S.A 105:2128-2133 (2008); Sohling et al., J Bacteriol. 178:871-880 (1996)). Similar CoA transferase activities are also present in Trichomonas vaginalis, Trypanosoma brucei, Clostridium aminobutyricum and Porphyromonas gingivalis (Riviere et al., J. Biol. Chem. 279:45337-45346 (2004); van Grinsven et al., J. Biol. Chem. 283:1411-1418 (2008)).
Clostridium kluyveri
Clostridium kluyveri
Clostridium kluyveri
Trichomonas
vaginalis G3
Trypanosoma brucei
Clostridium
aminobutyricum
Porphyromonas
gingivalis W83
A fatty acyl-CoA transferase that utilizes acetyl-CoA as the CoA donor is acetoacetyl-CoA transferase, encoded by the E. coli atoA (alpha subunit) and atoD (beta subunit) genes (Korolev et al., Acta Crystallogr. D. Biol. Crystallogr. 58:2116-2121 (2002); Vanderwinkel et al., 33:902-908 (1968)). This enzyme has a broad substrate range on substrates of chain length C3-C6 (Sramek et al., Arch Biochem Biophys 171:14-26 (1975)) and has been shown to transfer the CoA moiety to acetate from a variety of branched and linear 3-oxo and acyl-CoA substrates, including isobutyrate (Matthies et al., Appl Environ. Microbiol 58:1435-1439 (1992)), valerate (Vanderwinkel et al., Biochem. Biophys. Res. Commun. 33:902-908 (1968)) and butanoate (Vanderwinkel et al., Biochem. Biophys. Res. Commun. 33:902-908 (1968)). This enzyme is induced at the transcriptional level by acetoacetate, so modification of regulatory control may be necessary for engineering this enzyme into a pathway (Pauli et al., Eur. J Biochem. 29:553-562 (1972)). Similar enzymes exist in Corynebacterium glutamicum ATCC 13032 (Duncan et al., 68:5186-5190 (2002)), Clostridium acetobutylicum (Cary et al., Appl Environ Microbiol 56:1576-1583 (1990); Wiesenborn et al., Appl Environ Microbiol 55:323-329 (1989)), and Clostridium saccharoperbutylacetonicum (Kosaka et al., Biosci. Biotechnol Biochem. 71:58-68 (2007)).
Escherichia coli
Escherichia coli
Corynebacterium glutamicum
Corynebacterium glutamicum
Clostridium acetobutylicum
Clostridium acetobutylicum
Clostridium
saccharoperbutylacetonicum
Clostridium
saccharoperbutylacetonicum
Exemplary enzymes for catalyzing the decarboxylation of 2,4-pentadienoate (1H, 2G, 3L), 4-hydroxypent-2-enoate (1T), 5-hydroxypent-2-enoate (2P) and 4-hydroxypent-2-enoate (3E) are sorbic acid decarboxylase, aconitate decarboxylase, 4-oxalocrotonate decarboxylase and cinnamate decarboxylase.
Sorbic acid decarboxylase converts sorbic acid to 1,3-pentadiene. Sorbic acid decarboxylation by Aspergillus niger requires three genes: padA1, ohbA1, and sdrA (Plumridge et al. Fung. Genet. Bio, 47:683-692 (2010). PadA1 is annotated as a phenylacrylic acid decarboxylase, ohbA1 is a putative 4-hydroxybenzoic acid decarboxylase, and sdrA is a sorbic acid decarboxylase regulator. Additional species have also been shown to decarboxylate sorbic acid including several fungal and yeast species (Kinderlerler and Hatton, Food Addit Contam., 7(5):657-69 (1990); Casas et al., Int J Food Micro., 94(1):93-96 (2004); Pinches and Apps, Int. J. Food Microbiol. 116: 182-185 (2007)). For example, Aspergillus oryzae and Neosartorya fischeri have been shown to decarboxylate sorbic acid and have close homologs to padA1, ohbA1, and sdrA.
Aspergillus niger
Aspergillus niger
Aspergillus niger
Aspergillus oryzae
Aspergillus oryzae
Aspergillus oryzae
Neosartorya fischeri
Neosartorya fischeri
Neosartorya fischeri
Aconitate decarboxylase (EC 4.1.1.6) catalyzes the final step in itaconate biosynthesis in a strain of Candida and also in the filamentous fungus Aspergillus terreus (Bonnarme et al. J Bacteriol. 177:3573-3578 (1995); Willke and Vorlop, Appl Microbiol. Biotechnol 56:289-295 (2001)). A cis-aconitate decarboxylase (CAD) (EC 4.1.16) has been purified and characterized from Aspergillus terreus (Dwiarti et al., J. Biosci. Bioeng. 94(1): 29-33 (2002)). Recently, the gene has been cloned and functionally characterized (Kanamasa et al., Appl. Microbiol Biotechnol 80:223-229 (2008)) and (WO/2009/014437). Several close homologs of CAD are listed below (EP 2017344A1; WO 2009/014437 A1). The gene and protein sequence of CAD were reported previously (EP 2017344 A1; WO 2009/014437 A1), along with several close homologs listed in the table below.
Aspergillus terreus
Aspergillus terreus
Aspergillus terreus
Aspergillus oryzae
Aspergillus niger
Gibberella zeae
Aspergillus niger
Pichia stipitis
Mycobacterium
smegmatis
Mycobacterium avium
Mycobacterium avium
Salinispora arenicola
An additional class of decarboxylases has been characterized that catalyze the conversion of cinnamate (phenylacrylate) and substituted cinnamate derivatives to the corresponding styrene derivatives. These enzymes are common in a variety of organisms and specific genes encoding these enzymes that have been cloned and expressed in E. coli are: pad 1 from Saccharomyces cerevisae (Clausen et al., Gene 142:107-112 (1994)), pdc from Lactobacillus plantarum (Barthelmebs et al., 67:1063-1069 (2001); Qi et al., Metab Eng 9:268-276 (2007); Rodriguez et al., J. Agric. Food Chem. 56:3068-3072 (2008)), pofK (pad) from Klebsiella oxytoca (Uchiyama et al., Biosci. Biotechnol. Biochem. 72:116-123 (2008); Hashidoko et al., Biosci. Biotech. Biochem. 58:217-218 (1994)), Pedicoccus pentosaceus (Barthelmebs et al., 67:1063-1069 (2001)), and padC from Bacillus subtilis and Bacillus pumilus (Shingler et al., 174:711-724 (1992)). A ferulic acid decarboxylase from Pseudomonas fluorescens also has been purified and characterized (Huang et al., J. Bacteriol. 176:5912-5918 (1994)). Importantly, this class of enzymes have been shown to be stable and do not require either exogenous or internally bound co-factors, thus making these enzymes ideally suitable for biotransformations (Sariaslani, Annu. Rev. Microbiol. 61:51-69 (2007)).
Saccharomyces cerevisae
Saccharomyces cerevisiae
Lactobacillus plantarum
Klebsiella oxytoca
Bacillus subtilis
Pedicoccus pentosaceus
Bacillus pumilus
4-Oxalocronate decarboxylase catalyzes the decarboxylation of 4-oxalocrotonate to 2-oxopentanoate. This enzyme has been isolated from numerous organisms and characterized. The decarboxylase typically functions in a complex with vinylpyruvate hydratase. Genes encoding this enzyme include dmpH and dmpE in Pseudomonas sp. (strain 600) (Shingler et al., 174:711-724 (1992)), xylII and xylIII from Pseudomonas putida (Kato et al., Arch. Microbiol 168:457-463 (1997); Stanley et al., Biochemistry 39:3514 (2000); Lian et al., J. Am. Chem. Soc. 116:10403-10411 (1994)) and Reut_B5691 and Reut_B5692 from Ralstonia eutropha JMP134 (Hughes et al., J Bacteriol, 158:79-83 (1984)). The genes encoding the enzyme from Pseudomonas sp. (strain 600) have been cloned and expressed in E. coli (Shingler et al., J. Bacteriol. 174:711-724 (1992)). The 4-oxalocrotonate decarboxylase encoded by xylI in Pseudomonas putida functions in a complex with vinylpyruvate hydratase. A recombinant form of this enzyme devoid of the hydratase activity and retaining wild type decarboxylase activity has been characterized (Stanley et al., Biochem. 39:718-26 (2000)). A similar enzyme is found in Ralstonia pickettii (formerly Pseudomonas pickettii) (Kukor et al., J Bacteriol. 173:4587-94 (1991)).
Pseudomonas sp. CF600
Pseudomonas sp. CF600
Pseudomonas putida
Pseudomonas putida
Ralstonia eutropha
Pseudomonas putida
Pseudomonas putida
Ralstonia pickettii
Pseudomonas fluorescens
Numerous characterized enzymes decarboxylate amino acids and similar compounds, including aspartate decarboxylase, lysine decarboxylase and ornithine decarboxylase. Aspartate decarboxylase (EC 4.1.1.11) decarboxylates aspartate to form beta-alanine. This enzyme participates in pantothenate biosynthesis and is encoded by gene panD in Escherichia coli (Dusch et al., Appl. Environ. Microbiol 65:1530-1539 (1999); Ramjee et al., Biochem. J 323 (Pt 3):661-669 (1997); Merkel et al., FEMS Microbiol Lett. 143:247-252 (1996); Schmitzberger et al., EMBO J 22:6193-6204 (2003)). The enzymes from Mycobacterium tuberculosis (Chopra et al., Protein Expr. Purif. 25:533-540 (2002)) and Corynebacterium glutanicum (Dusch et al., Appl. Environ. Microbiol 65:1530-1539 (1999)) have been expressed and characterized in E. coli.
Escherichia coli K12
Corynebacterium glutanicum
Mycobacterium tuberculosis
Lysine decarboxylase (EC 4.1.1.18) catalyzes the decarboxylation of lysine to cadaverine. Two isozymes of this enzyme are encoded in the E. coli genome by genes cadA and ldcC. CadA is involved in acid resistance and is subject to positive regulation by the cadC gene product (Lemonnier et al., Microbiology 144 (Pt 3):751-760 (1998)). CadC accepts hydroxylysine and S-aminoethylcysteine as alternate substrates, and 2-aminopimelate and 6-aminocaproate act as competitive inhibitors to this enzyme (Sabo et al., Biochemistry 13:662-670 (1974)). The constitutively expressed ldc gene product is less active than CadA (Lemonnier and Lane, Microbiology 144 (Pt 3):751-760 (1998)). A lysine decarboxylase analogous to CadA was recently identified in Vibrio parahaemolyticus (Tanaka et al., J Appl Microbiol 104:1283-1293 (2008)). The lysine decarboxylase from Selenomonas ruminantium, encoded by ldc, bears sequence similarity to eukaryotic ornithine decarboxylases, and accepts both L-lysine and L-ornithine as substrates (Takatsuka et al., Biosci. Biotechnol Biochem. 63:1843-1846 (1999)). Active site residues were identified and engineered to alter the substrate specificity of the enzyme (Takatsuka et al., J Bacteriol. 182:6732-6741 (2000)). Several ornithine decarboxylase enzymes (EC 4.1.1.17) also exhibit activity on lysine and other similar compounds. Such enzymes are found in Nicotiana glutinosa (Lee et al., Biochem. J 360:657-665 (2001)), Lactobacillus sp. 30a (Guirard et al., J Biol. Chem. 255:5960-5964 (1980)) and Vibrio vulnificus (Lee et al., J Biol. Chem. 282:27115-27125 (2007)). The enzymes from Lactobacillus sp. 30a (Momany et al., J Mol. Biol. 252:643-655 (1995)) and V. vulnificus have been crystallized. The V. vulnificus enzyme efficiently catalyzes lysine decarboxylation and the residues involved in substrate specificity have been elucidated (Lee et al., J Biol. Chem. 282:27115-27125 (2007)). A similar enzyme has been characterized in Trichomonas vaginalis but the gene encoding this enzyme is not known (Yarlett et al., Biochem. J 293 (Pt 2):487-493 (1993)).
Escherichia
coli
Escherichia
coli
Selenomonas
ruminantium
Vibrio para-
haemolyticus
Nicotiana
glutinosa
Lactobacillus
Vibrio
vulnificus
An exemplary carboxy-lyase for decarboxylating 2-hydroxypent-3-enoate (1S) is acetolactate decarboxylase (4.1.1.5) which participates in citrate catabolism and branched-chain amino acid biosynthesis, converting the 2-hydroxyacid, 2-acetolactate, to acetoin. In Lactococcus lactis the enzyme is composed of six subunits, encoded by gene aldB, and is activated by valine, leucine and isoleucine (Goupil-Feuillerat et al., J. Bacteriol. 182:5399-5408 (2000); Goupil et al., Appl. Environ. Microbiol. 62:2636-2640 (1996)). This enzyme has been overexpressed and characterized in E. coli (Phalip et al., FEBS Lett. 351:95-99 (1994); Nielsen et al, Biotechnol J 5:274-84 (2010)). In other organisms the enzyme is a dimer, encoded by aldC in Streptococcus thermophilus (Monnet et al., Lett. Appl. Microbiol. 36:399-405 (2003)), aldB in Bacillus brevis (Najmudin et al., Acta Crystallogr. D. Biol. Crystallogr. 59:1073-1075 (2003); Diderichsen et al., J. Bacteriol. 172:4315-4321 (1990)) and budA from Enterobacter aerogenes (Diderichsen et al., J. Bacteriol. 172:4315-4321 (1990)). The enzyme from Bacillus brevis was cloned and overexpressed in Bacillus subtilis and characterized crystallographically (Najmudin et al., Acta Crystallogr. D. Biol. Crystallogr. 59:1073-1075 (2003)). The Acetobacter aceti acetolactate decarboxylase was cloned and heterologously expressed in brewer's yeast (Yamano et al, J Biotechnol 32:165-71 (1994)). Additionally, the enzyme from Leuconostoc lactis has been purified and characterized but the gene has not been isolated (O'Sullivan et al., FEMS Microbiol. Lett. 194:245-249 (2001)).
Lactococcus lactis
Streptococcus thermophilus
Bacillus brevis
Enterobacter aerogenes
Acetobacter aceti
Tartrate decarboxylase (EC 4.1.1.73) carries out an alpha,beta-hydroxyacid decarboxylation reaction. The enzyme, characterized in Pseudomonas sp. group Ve-2, is NAD+ dependent and catalyzes coupled oxidation-reduction reaction that proceeds through an oxaloglycolate intermediate (Furuyoshi et al., J Biochem. 110:520-525 (1991)). A side reaction catalyzed by this enzyme is the NAD+ dependent oxidation of tartrate (1% of activity). A gene has not been associated with this enzyme activity to date.
The decarboxylation of keto-acids such as 4-hydroxy 2-oxovalerate, 2-oxopent-3-enoate as shown in Steps 1C and 1I is catalyzed by a variety of enzymes with varied substrate specificities, including pyruvate decarboxylase (EC 4.1.1.1), benzoylformate decarboxylase (EC 4.1.1.7), alpha-ketoglutarate decarboxylase and branched-chain alpha-ketoacid decarboxylase. Pyruvate decarboxylase (PDC), also termed keto-acid decarboxylase, is a key enzyme in alcoholic fermentation, catalyzing the decarboxylation of pyruvate to acetaldehyde. The enzyme from Saccharomyces cerevisiae has a broad substrate range for aliphatic 2-keto acids including 2-ketobutyrate, 2-ketovalerate, 3-hydroxypyruvate and 2-phenylpyruvate (22). This enzyme has been extensively studied, engineered for altered activity, and functionally expressed in E. coli (Killenberg-Jabs et al., Eur. J. Biochem. 268:1698-1704 (2001); Li et al., Biochemistry. 38:10004-10012 (1999); ter Schure et al., Appl. Environ. Microbiol. 64:1303-1307 (1998)). The PDC from Zymomonas mobilus, encoded by pdc, also has a broad substrate range and has been a subject of directed engineering studies to alter the affinity for different substrates (Siegert et al., Protein Eng Des Sel 18:345-357 (2005)). The crystal structure of this enzyme is available (Killenberg-Jabs et al., Eur. J. Biochem. 268:1698-1704 (2001)). Other well-characterized PDC candidates include the enzymes from Acetobacter pasteurians (Chandra et al., 176:443-451 (2001)) and Kluyveromyces lactis (Krieger et al., 269:3256-3263 (2002)).
Zymomonas mobilis
Saccharomyces cerevisiae
Acetobacter pasteurians
Kluyveromyces lactis
Like PDC, benzoylformate decarboxylase (EC 4.1.1.7) has a broad substrate range and has been the target of enzyme engineering studies. The enzyme from Pseudomonas putida has been extensively studied and crystal structures of this enzyme are available (Polovnikova et al., 42:1820-1830 (2003); Hasson et al., 37:9918-9930 (1998)). Site-directed mutagenesis of two residues in the active site of the Pseudomonas putida enzyme altered the affinity (Km) of naturally and non-naturally occurring substrates (Siegert et al., Protein Eng Des Sel 18:345-357 (2005)). The properties of this enzyme have been further modified by directed engineering (Lingen et al., Chembiochem. 4:721-726 (2003); Lingen et al., Protein Eng 15:585-593 (2002)). The enzyme from Pseudomonas aeruginosa, encoded by mdlC, has also been characterized experimentally (Barrowman et al., 34:57-60 (1986)). Additional gene candidates from Pseudomonas stutzeri, Pseudomonas fluorescens and other organisms can be inferred by sequence homology or identified using a growth selection system developed in Pseudomonas putida (Henning et al., Appl. Environ. Microbiol. 72:7510-7517 (2006)).
Pseudomonas
putida
Pseudomonas
aeruginosa
Pseudomonas
stutzeri
Pseudomonas
fluorescens
A third enzyme capable of decarboxylating 2-oxoacids is alpha-ketoglutarate decarboxylase (KGD, EC 4.1.1.71). The substrate range of this class of enzymes has not been studied to date. An exemplary KDC is encoded by kgd in Mycobacterium tuberculosis (Tian et al., PNAS 102:10670-10675 (2005)). KDC enzyme activity has also been detected in several species of rhizobia including Bradyrhizobium japonicum and Mesorhizobium loti (Green et al., J Bacteriol 182:2838-2844 (2000)). Although the KDC-encoding gene(s) have not been isolated in these organisms, the genome sequences are available and several genes in each genome are annotated as putative KDCs. A KDC from Euglena gracilis has also been characterized but the gene associated with this activity has not been identified to date (Shigeoka et al., Arch. Biochem. Biophys. 288:22-28 (1991)). The first twenty amino acids starting from the N-terminus were sequenced MTYKAPVKDVKFLLDKVFKV (Shigeoka and Nakano, Arch. Biochem. Biophys. 288:22-28 (1991)). The gene could be identified by testing candidate genes containing this N-terminal sequence for KDC activity.
Mycobacterium
tuberculosis
Bradyrhizobium
japonicum
Mesorhizobium
loti
A fourth candidate enzyme for catalyzing this reaction is branched chain alpha-ketoacid decarboxylase (BCKA). This class of enzyme has been shown to act on a variety of compounds varying in chain length from 3 to 6 carbons (Oku et al., J Biol Chem. 263:18386-18396 (1988); Smit et al., Appl Environ Microbiol 71:303-311 (2005)). The enzyme in Lactococcus lactis has been characterized on a variety of branched and linear substrates including 2-oxobutanoate, 2-oxohexanoate, 2-oxopentanoate, 3-methyl-2-oxobutanoate, 4-methyl-2-oxobutanoate and isocaproate (Smit et al., Appl Environ Microbiol 71:303-311 (2005)). The enzyme has been structurally characterized (Berg et al., Science. 318:1782-1786 (2007)). Sequence alignments between the Lactococcus lactis enzyme and the pyruvate decarboxylase of Zymomonas mobilus indicate that the catalytic and substrate recognition residues are nearly identical (Siegert et al., Protein Eng Des Sel 18:345-357 (2005)), so this enzyme would be a promising candidate for directed engineering. Decarboxylation of alpha-ketoglutarate by a BCKA was detected in Bacillus subtilis; however, this activity was low (5%) relative to activity on other branched-chain substrates (Oku and Kaneda, J Biol Chem. 263:18386-18396 (1988)) and the gene encoding this enzyme has not been identified to date. Additional BCKA gene candidates can be identified by homology to the Lactococcus lactis protein sequence. Many of the high-scoring BLASTp hits to this enzyme are annotated as indolepyruvate decarboxylases (EC 4.1.1.74). Indolepyruvate decarboxylase (IPDA) is an enzyme that catalyzes the decarboxylation of indolepyruvate to indoleacetaldehyde in plants and plant bacteria. Recombinant branched chain alpha-keto acid decarboxylase enzymes derived from the E1 subunits of the mitochondrial branched-chain keto acid dehydrogenase complex from Homo sapiens and Bos taurus have been cloned and functionally expressed in E. coli (Davie et al., J. Biol. Chem. 267:16601-16606 (1992); Wynn et al., J. Biol. Chem. 267:12400-12403 (1992); Wynn et al., J. Biol. Chem. 267:1881-1887 (1992)). In these studies, the authors found that co-expression of chaperonins GroEL and GroES enhanced the specific activity of the decarboxylase by 500-fold (Wynn et al., J. Biol. Chem. 267:12400-12403 (1992)). These enzymes are composed of two alpha and two beta subunits.
Lactococcus
lactis
Mycobacterium
tuberculosis
Homo
sapiens
Homo
sapiens
Bos
taurus
Bos
taurus
The acetolactate synthase from Bacillus subtilis (AlsS), which naturally catalyzes the condensation of two molecules of pyruvate to form 2-acetolactate, is also able to catalyze the decarboxylation of 2-ketoisovalerate like KDC both in vivo and in vitro [PMID=19684168].
The dehydration of 2-hydroxypent-3-enoyl-CoA (1P), 3-hydroxypent-4-enoyl-CoA (2O), 3,4-dihydroxypentanoyl-CoA (3H), 4-hydroxy pent-2-enoyl-CoA (3M) and 5-hydroxypent-2-enoyl-CoA (2N) can be catalyzed by a special class of oxygen-sensitive enzymes that dehydrate 2-hydroxyacyl-CoA derivatives by a radical-mechanism (Buckel and Golding, Annu. Rev. Microbiol. 60:27-49 (2006); Buckel et al., Curr. Opin. Chem. Biol. 8:462-467 (2004); Buckel et al., Biol. Chem. 386:951-959 (2005); Kim et al., FEBS J. 272:550-561 (2005); Kim et al., FEMS Microbiol. Rev. 28:455-468 (2004); Zhang et al., Microbiology 145 (Pt 9):2323-2334 (1999)). One example of such an enzyme is the lactyl-CoA dehydratase from Clostridium propionicum, which catalyzes the dehydration of lactoyl-CoA to form acryloyl-CoA (Kuchta and Abeles, J. Biol. Chem. 260:13181-13189 (1985); Hofmeister and Buckel, Eur. J. Biochem. 206:547-552 (1992)). An additional example is 2-hydroxyglutaryl-CoA dehydratase encoded by hgdABC from Acidaminococcus fermentans (Muëller and Buckel, Eur. J. Biochem. 230:698-704 (1995); Schweiger et al., Eur. J. Biochem. 169:441-448 (1987)). Purification of the dehydratase from A. fermentans yielded two components, A and D. Component A (HgdC) acts as an activator or initiator of dehydration. Component D is the actual dehydratase and is encoded by HgdAB. Variations of this enzyme have been found in Clostridium symbiosum and Fusobacterium nucleatum. Component A, the activator, from A. fermentans is active with the actual dehydratse (component D) from C. symbiosum and is reported to have a specific activity of 60 per second, as compared to 10 per second with the component D from A. fermentans. Yet another example is the 2-hydroxyisocaproyl-CoA dehydratase from Clostridium difficile catalyzed by hadBC and activated by hadI (Darley et al., FEBS J. 272:550-61 (2005)). The sequence of the complete C. propionicium lactoyl-CoA dehydratase is not yet listed in publicly available databases. However, the sequence of the beta-subunit corresponds to the GenBank accession number AJ276553 (Selmer et al, Eur J Biochem, 269:372-80 (2002)). The dehydratase from Clostridium sporogens that dehydrates phenyllactyl-CoA to cinnamoyl-CoA is also a potential candidate for this step. This enzyme is composed of three subunits, one of which is a CoA transferase. The first step comprises of a CoA transfer from cinnamoyl-CoA to phenyllactate leading to the formation of phenyllactyl-CoA and cinnamate. The product cinnamate is released. The dehydratase then converts phenyllactyl-CoA into cinnamoyl-CoA. FldA is the CoA transferase and FldBC are related to the alpha and beta subunits of the dehydratase, component D, from A. fermentans.
Acidaminococcus
fermentans
Acidaminococcus
fermentans
Acidaminococcus
fermentans
Clostridum
symbiosum
Clostridum
symbiosum
Clostridum
symbiosum
Fusobacterium
nucleatum
Fusobacterium
nucleatum
Fusobacterium
nucleatum
Clostridium
sporogens
Clostridium
sporogens
Clostridium
difficile
Clostridium
difficile
Clostridium
difficile
Clostridium
propionicum
Another dehydratase that can potentially conduct such a biotransformation is the enoyl-CoA hydratase (4.2.1.17) of Pseudomonas putida, encoded by ech that catalyzes the conversion of 3-hydroxybutyryl-CoA to crotonyl-CoA (Roberts et al., Arch. Microbiol 117:99-108 (1978)). This transformation is also catalyzed by the crt gene product of Clostridium acetobutylicum, the crt1 gene product of C. kluyveri, and other clostridial organisms Atsumi et al., Metab Eng 10:305-311 (2008); Boynton et al., J Bacteriol. 178:3015-3024 (1996); Hillmer et al., FEBS Lett. 21:351-354 (1972)). Additional enoyl-CoA hydratase candidates are phaA and phaB, of P. putida, and paaA and paaB from P. fluorescens (Olivera et al., Proc. Natl. Acad. Sci U.S.A 95:6419-6424 (1998)). The gene product of pimF in Rhodopseudomonas palustris is predicted to encode an enoyl-CoA hydratase that participates in pimeloyl-CoA degradation (Harrison et al., Microbiology 151:727-736 (2005)). Lastly, a number of Escherichia coli genes have been shown to demonstrate enoyl-CoA hydratase functionality including maoC (Park et al., J Bacteriol. 185:5391-5397 (2003)), paaF (Ismail et al., Eur. J Biochem. 270:3047-3054 (2003); Park et al., Appl. Biochem. Biotechnol 113-116:335-346 (2004); Park et al., Biotechnol Bioeng 86:681-686 (2004)) and paaG (Ismail et al., Eur. J Biochem. 270:3047-3054 (2003); Park and Lee, Appl. Biochem. Biotechnol 113-116:335-346 (2004); Park and Yup, Biotechnol Bioeng 86:681-686 (2004)).
Pseudomonas
putida
Clostridium
acetobutylicum
Clostridium
kluyveri
Pseudomonas
putida KT2440
Pseudomonas
putida KT2440
Pseudomonas
fluorescens
Pseudomonas
fluorescens
Escherichia
coli
Escherichia
coli
Escherichia
coli
Alternatively, the E. coli gene products of fadA and fadB encode a multienzyme complex involved in fatty acid oxidation that exhibits enoyl-CoA hydratase activity (Yang et al., Biochemistry 30:6788-6795 (1991); Yang, J Bacteriol. 173:7405-7406 (1991); Nakahigashi et al., Nucleic Acids Res. 18:4937 (1990)). Knocking out a negative regulator encoded byfadR can be utilized to activate the fadB gene product (Sato et al., J Biosci. Bioeng 103:38-44 (2007)). The fadI and fadJ genes encode similar functions and are naturally expressed under anaerobic conditions (Campbell et al., Mol. Microbiol 47:793-805 (2003)).
Escherichia
coli
Escherichia
coli
Escherichia
coli
Escherichia
coli
Escherichia
coli
The dehydration of crotyl alcohol (1M, 4H), methyl vinyl carbinol (1L, 2Q, 3F, 4G), 3-hydroxybutyraldehyde (1D), 4-hydroxy-2-oxovalerate (1E, 2C), 2-hydroxy pent3-enoate (1G), 4-hydroxypent-2-enoate (1V, 3K), 5-hydroxypent-2-enoate (2F), 3-hydroxypent-4-enoate (2R) and 3,4-dihydroxypentanoate (3D) can be catalyzed exemplary dehydratases including oleate hydratase, acyclic 1,2-hydratase, linalool dehydratase, dimethylmaleate hydratase, (S)-2-methylmalate dehydratase, fumarate hydratase, glycerol dehydratase and enoyl-CoA hydratase enzymes. Enzyme candidates are described below.
Alternatively, crotyl alcohol, 3-buten-2-ol and 3-buten-1-ol produced by culturing the non-naturally occurring microbial organisms described herein can be converted to butadiene by chemical dehydration in the presence of a chemical catalyst. For example see international patent application publication WO2012106516A1.
Oleate hydratases catalyze the reversible hydration of non-activated alkenes to their corresponding alcohols. Oleate hydratase enzymes disclosed in WO2011/076691 and WO 2008/119735 are incorporated by reference herein. Oleate hydratases from Elizabethkingia meningoseptica and Streptococcus pyogenes are encoded by ohyA and HMPREF0841_1446. Acyclic 1,2-hydratase enzymes (eg. EC 4.2.1.131) catalyze the dehydration of linear secondary alcohols, and are thus suitable candidates for the dehydration of MVC to butadiene. Exemplary 1,2-hydratase enzymes include carotenoid 1,2-hydratase, encoded by crtC of Rubrivivax gelatinosus (Steiger et al, Arch Biochem Biophys 414:51-8 (2003)), and lycopene 1,2-hydratase, encoded by cruF of Synechococcus sp. PCC 7002 and Gemmatimonas aurantiaca (Graham and Bryant, J Bacteriol 191: 2392-300 (2009); Takaichi et al, Microbiol 156: 756-63 (2010)). Dehydration of t-butyl alcohol, t-amyl alcohol and 2-methyl-MVC to isobutene, isoamylene and isoprene, respectively, is catalyzed by an unknown enzyme of Aquincola tertiaricarbonis L108 (Schaefer et al, AEM 78 (17): 6280-4 (2012); Schuster et al, J. Bacteriol 194:972-81 (2012); Schuster et al, J Bacteriol 194: 972-81 (2012)). Linalool dehydratase/isomerase of Castellaniella defragrans catalyzes the dehydration of linalool to myrcene (Brodkorb et al, J Biol Chem 285:30436-42 (2010)). Enzyme accession numbers and homologs are listed in the table below.
Elizabethkingia
meningoseptica
Streptococcus
pyogenes ATCC 10782
Psychroflexus
torquis ATCC 700755
Rhodopseudomonas
palustris
Rubrivivax
gelatinosus
Synechococcus sp. PCC 7002
Castellaniella
defragrans
Colletotrichum
gloeosporioides
Nara gc5
Togninia
minima UCRPA7
Neofusicoccum
parvum UCRNP2
Stereum
hirsutum FP-91666 SS1
Nectria
haematococca mpVI 77-13-4
Amycolicicoccus
subflavus DQS3-9A1
Dimethylmaleate hydratases catalyze the dehydration of (2R,3S)-2,3-dimethylmalate into dimethylmaleate (EC 4.2.1.85). Dimethylmaleate hydratases from Eubacterium barkeri are encoded by dmdA and dmdB (Alhapel et al., Proc Natl Acad Sci 103:12341-6 (2006)). (S)-2-methylmalate dehydratases catalyze the reversible hydration of mesaconate to citramalate (EC 4.2.1.34). An exemplary (S)-2-methylmalate dehydratase is encoded by LeuC and LeuD of Methanococcus jannaschii and has been shown to catalyze the second steop in the leucine biosynthesis pathway (Lee et al, Biochem Biophys Res Commun 419(2):160-4 (2012)). Fumarate hydratases catalyze the interconversion of fumarate to malate (EC 4.2.1.2). Two classes of fumarate hydratases exist, where classification is dependent upon the arrangement of subunits and metal requirements. Exemplary class I and class II fumarate dehydratases are encoded by fumA and fumC of Escherichia coli (Tseng et al, J Bacteriol 183(2):461-7 (2001)), and fumC of Corynebacterium glutamicum (Genda et al, Biosci Biotechnol Biochem 70(5):1102-9 (2006)). Glycerol dehydratases (EC 4.2.1.30) catalyze the conversion of glycerol to 3-hydroxy-propionaldehyde and water. Exemplary glycerol dehydratases are encoded by dhaB of Klebsiella pneumoniae (Wang et al, Biotechnol J. 2(6):736-42, (2007)) and by dhaB of Citrobacter freundii (Seyfried et al, J Bacteriol. 178(19):5793-6 (1996)). Enoyl-CoA hydratases catalyze the hydration of the double bond between the second and third carbons on acyl-CoA (EC 4.2.1.17). Enoyl-CoA hydratases are involved in the breakdown of fatty acids. Exemplary enoyl-CoA hydratases are encoded by phaJ1 of Pseudomonas putida (Vo et al, J. Biosci. Bioeng. 106 (1), 95-98 (2008)), and paaF of Escherichia coli (Teufel et al, Proc Natl Acad Sci USA. 107(32):14390-5 (2010)).
Eubacterium
barkeri
Eubacterium
barkeri
Methanococcus
jannaschii
Methanococcus
jannaschii
Escherichia
coli
Escherichia
coli
Corynebacterium
glutamicum
Pseudomonas
putida
Escherichia
coli
Klebsiella
pneumoniae
Citrobacter
freundii
Bifunctional enzymes with dehydratase and isomerase activities are suitable for dehydrating and rearranging alcohols to alkenes as shown in
Castellaniella
defragrans
Colletotrichum
gloeosporioides
Nara gc5
Togninia
minima UCRPA7
Neofusicoccum
parvum
Stereum
hirsutum FP-91666
Nectria
haematococca mpVI
Amycolicicoccus
subflavus
Alternatively, a fusion protein or protein conjugate can be generated using well know methods in the art to generate a bi-functional (dual-functional) enzyme having both the isomerase and dehydratase activities. The fusion protein or protein conjugate can include at least the active domains of the enzymes (or respective genes) of the isomerase and dehydratase reactions. For the first step, the conversion of CrotOH to 3-buten-2-ol or 2-hydroxypent-3-enoate to 2,4-pentadienoate, enzymatic conversion can be catalyzed by a CrotOH or 2-hydroxypent-3-enoate isomerase (classified as EC 5.3.3 and EC 5.4.4). A similar isomerization, the conversion of 2-methyl-MVC to 3-methyl-2-buten-1-ol, is catalyzed by cell extracts of Pseudomonas putida MB-1 (Malone et at, AEM 65 (6): 2622-30 (1999)). The extract may be used in vitro, or the protein or gene(s) associated with the isomerase activity can be isolated and used, even though they have not been identified to date. Alternatively, either or both steps can be done by chemical conversion, or by enzymatic conversion (in vivo or in vitro), or any combination. Crotyl alcohol can be converted to butadiene by chemical dehydration in the presence of a chemical catalyst. For example see international patent application publication WO2012106516A1.
Linalool dehydratase/isomerase, Genbank ID number 403399445, was cloned from Castellaniella defragrans 65Phen into a plasmid suitable for expression in E. coli., plasmid pZS*13S obtained from R. Lutz (Expressys, Germany) and are based on the pZ Expression System (Lutz, R. & Bujard, H. Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Res. 25, 1203-1210 (1997)).
E. coli variants were transformed with the expression plasmid and selected and maintained using antibiotic selection with carbenicillin. The day before the experiment, 1 mL overnight cultures in LB-antibiotic were inoculated and grown with a breathable seal in 24 well plate at 37° C. Overnight cultures were seeded at OD600=0.05 into fresh 2 mL M9+4% glucose+antibiotic+IPTG+10 mM crotyl alcohol into 10 ml screw-cap bottles. Bottles were incubated for 48 hours at 37° C. and 1,3-butadiene production was validated by headspace analysis by GC-MS. In the absence of enzyme, no production of 1,3-butadiene was observed.
Vinylisomerase catalyzes the conversion of Crotyl alcohol to MVC (1K, 4F), 2-hydroxypent-3-enoate to 4-hydroxypent-2-enoate (1U), 3-hydroxypent-4-enoyl-CoA to 5-hydroxypent-2-enoyl-CoA (2M) and 2-hydroxypent-4-enoate to 5-hydroxypent-2-enoate (2E). The conversion of 3-buten-1-ol to crotyl alcohol can be carried out by vinyl-isomerases (see
Particularly useful enzymes include isopentenyl-diphosphate Δ-isomerase, vinylacetyl-CoA Δ-isomerase and methylitaconate Δ-isomerase. Enzymes candidates are described below. Also useful is the vinylisomerase activity of linalool dehydratase.
Isopentenyl diphophaste isomerases catalyze the interconversion of isopentenyl diphosphate and dimethylallyl diphosphate, but can also catalyze the interconversion of CrotOH to MVC (EC 5.3.3.2). Exemplary isopentenyl diphophaste isomerases are encoded by IDI-2 of Thermus thermophilus (Sharma et al, Biochemistry 49(29): 6228-6233 (2010)), idi of Xanthophyllomyces dendrorhous and idi of Haematococcus pluvialis (Kajiwara et al, Biochem J 324(Pt 2): 421-426 (1997)). Crystal structures have been determined for the isopentenyl diphophaste isomerases from Escherichia coli (Durbecq et al, EMBO J 20(7): 1530-1537 (2001)) and from Methanocaldococcus jannaschii (Hoshino et al, Acta Crystallogr Sect F Struct Biol Cryst Commun 67(Pt 1): 101-103 (2011)). Enzyme accession numbers and homologs are listed in the table below.
Thermus
thermophilus
Methanocaldococcus
jannaschii
Escherichia
coli
Xanthophyllomyces
dendrorhous
Haematococcus
pluvialis
Micromonas
pusilla CCMP1545
Vinylacetyl-CoA Δ-isomerases catalyze the conversion of vinylacetyl-CoA to crotonyl-CoA (EC 5.3.3.3). Exemplary vinylacetyl-CoA Δ-isomerases are encoded by AbfD of Clostridium kluyveri (Scherf et al, Arch Microbiol 161(3):239-45 (1994)), abfD of Clostridium aminobutyricum (Scherf et al, Eur J Biochem 215(2):421-9 (1993)), and Msed_1321 of Metallosphaera sedula (Auernik et al, Appl Environ Microbiol 74(3):682-92 (2008)).
Clostridium
kluyveri
Clostridium
aminobutyricum
Metallosphaera
sedula
Methylitaconate Δ-isomerases catalyze the isomerization of itaconate (methylenesuccinate) to citraconate (methylmaleate) (EC 5.3.3.6). An exemplary methylitaconate Δ-isomerase is encoded by mii from Eubacterium barkeri (Alhapel et al, Proc Natl Acad Sci USA 103(33):12341-6 (2006)) and the crystal structure of this 3-methylitaconate-delta-isomerase has been determined (Velarde et al, J Mol Biol 391(3):609-20 (2009)). Enzyme accession numbers and homologs are listed in the table below.
Eubacterium
barkeri
Clostridiales
bacterium
Sporomusa
ovata
Alcohol mutases that catalyze the conversion of 2-hydroxypent-4-enoate to 5-hydroxypent-2-enoate (2E) and 2-hydroxypent-4-enoate to 3-hydroxypent-4-enoate (2H) are found in the EC 5.4.4 enzyme class, which include isomerases that transfer hydroxyl groups. Exemplary isomerase enzymes suitable for the conversion of 2-hydroxypent-4-enoate to 5-hydroxypent-2-enoate include isochorismate synthase (EC 5.4.4.2) and geraniol isosmerase (EC 5.4.4.4). Isochorismate synthase catalyzes the isomerization of chorismate to isochorismate and encodes for essential components of the respiratory chain. Exemplary isochorismate synthases are encoded by menF and dhbC of Bacillus subtilis (Rowland et al, J Bacteriol. 178(3):854-61 (1996)) and by menF of Escherichia coli (Damnwala et al, J Bacteriol. 179(10):3133-8 (1997)). Geraniol isomerase catalyzes the isomerization of (3S)-linalool to geraniol. Exemplary geraniol isomerase is encoded by Ldi of Castellaniella defragrans (Brodkorb et al, J Biol Chem 285:30436-42 (2010)). Enzyme accession numbers and homologs are listed in the table below.
Bacillus
subtilis
Bacillus
subtilis
Escherichia
coli
Castellaniella
defragrans
Colletotrichum
gloeosporioides
Nara gc5
Togninia
minima UCRPA7
Alkenol synthase catalyzes the conversion of 2-butenyl-4-phosphate and 2-butenyl-4-diphosphate to 3-buten-2-ol or MVC (4D and 4E respectively). The enzymes described below naturally possess such activity or can be engineered to exhibit this activity. Particularly useful enzymes include methylbutenol (MBO) synthase, linalool synthase and nerolidol synthase. Enzyme candidates are described below and found within EC 4.2.3.
Methylbutenol synthase naturally catalyzes the conversion of dimethylallyl diphosphate to methylbutenol, but can also catalyze the synthesis of 3-buten-2-ol or MVC from 2-butenyl-4-phosphate and 2-butenyl-4-diphosphate. An exemplary methylbutenol synthase is encoded by Tps-MBO1 of Pinus sabiniana (Gray et al, J Biol Chem. 286(23):20582-90 (2011)). Linalool synthases catalyze the conversion of geranyl diphosphate to linalool. Exemplary R- (EC 4.2.3.26) and S-linalool synthases (EC 4.2.3.25) are encoded by AY083653 of Mentha citrata (Crowell et al, Arch Biochem Biophys., 405(1): 112-21 (2002)) and by Lis of Clarkia breweri (Dudareva et al, Plant Cell. 8(7): 1137-1148 (1996)), respectively. (3S, 6E)-nerolidol synthase (EC 4.2.3.48) catalyze the conversion of franesyl diphosphate to nerolidol. An exemplary (3S, 6E)-nerolidol synthase is encoded by MtTps3 of Medicago truncatula (Arimura et al, Planta. 227(2):453-64 (2008)). Enzyme accession numbers and homologs are listed in the table below.
Pinus
sabiniana
Picea
pungens
Mentha
citrata
Clarkia
breweri
Medicago
truncatula
Populus
trichocarpa
Butadiene synthase (monophosphate) or BDS
BDS (monophosphate) catalyzes the conversion of 2-butenyl-4-phosphate to 1,3-butadiene (Step 4J). BDS enzymes described above for Step C in the EC 4.2.3 enzyme class may possess such activity or can be engineered to exhibit this activity.
PadA1 (GI number: 1165293) and OhbA1 (GI number: 188496963) encoding phenylacrylate decarboxylase from S. cerevisiae were codon optimized by DNA 2.0 and were cloned by DNA 2.0 into the following vectors suitable for expression in E. coli, pD424-NH and pD441-NH respectively (DNA 2.0 Inc.,). The genes were tested for decarboxylation of 2,4-pentadienoate and the enzymatic reactions were carried out under the following conditions:
1.5 mg/ml lysate of E. coli DH5a cells containing decarboxylase from S. cerevisiae
The control reactions with lysate in the absence of substrate were conducted in parallel. 100 μL reactions were incubated overnight with shaking (175 rpm) at 25° C. in 1.5 ml gas-tight vials. Headspace GCMS analysis was carried out on a 7890A GC with 5975C inert MSD using a GS-GASPRO column, 30 m×0.32 mm (Agilent Technologies). Static headspace sample introduction was performed on a CombiPAL autosampler (CTC Analytics) following 2 min incubation at 45 C. The presence of 1,3-butadiene was evaluated and the enzymatic reaction product was identified by direct comparison with a standard of 1,3-butadiene (Sigma). GC/MS analysis showed the production of 1,3-butadiene from the enzymatic samples but not from the lysate alone controls.
While no butadiene formation was detected with the no substrate-control, butadiene was measured when 2,4-PD was added as a substrate.
Genes expressing acetyl-CoA reductase (bphJ from Burkholderia xenovorans LB400, GI no: 520923), 4-hydroxy 2-oxovalerate aldolase (bphI from Burkholderia xenovorans LB400, GI no: 520924), 4-hydroxy 2-oxovalerate decarboxylase (kdc from Mycobacterium tuberculosis BcG H37Rv, GI no: 614088617), and alcohol dehydrogenase (yjgB from Chronobacter sakazakii, GI no: 387852894) were cloned into a plasmid suitable for expression in E. coli, plasmid pZA23S (kanamycin resistance marker, p15A origin of replication) obtained from R. Lutz (Expressys, Germany) and are based on the pZ Expression System (Lutz, R. & Bujard, H. Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Res. 25, 1203-1210 (1997)).
E. coli (MG1655 variants) cells were transformed with the expression plasmid and selected and maintained using antibiotic selection with Kanamycin. Cells were grown for 72 hours in LB media with kanamycin and IPTG at 37° C. then harvested by centrifugation. The formation of a 4-carbon diol derived from 3-hydroxybutyraldehyde using glucose as the carbon substrate was measured (data not shown) while the empty vector control did not make any 4-carbon diol.
Isoprene synthase, E.C. 4.2.3.27, Genbank ID number 63108310, was cloned from Populus alba into a plasmid suitable for expression in E. coli., plasmid pZS*13S (Expressys, Germany).
E. coli (MG1655 variants) were transformed with the expression plasmid and selected and maintained using antibiotic selection with carbenicillin. Cells were grown in Terrific Broth with carbenicillin to an OD of 0.8 and then gene expression induced by IPTG addition then harvested by centrifugation. Lysis was performed using microfluidization at 0° C. Streptactin-tagged isoprene synthase was isolated from the cell lysate using Streptactin-Sepharose purification. Purified enzyme was tested for its ability to convert its native substrate, dimethylallyl diphosphate, into isoprene, and for its ability to convert crotyl diphosphate into 1, 3-butadiene, by incubating purified enzyme with each substrate in sealed screw-cap vials for a period of time before analysis of product in headspace of vial by GC-MS. Fidelity of purified enzyme was confirmed by detection of isoprene. Activity on crotyl diphosphate was confirmed by detection of butadiene. In the absence of enzyme, no butadiene was formed (data not shown).
Isopentenyl phosphate kinase, E.C. 2.7.4.26, Genbank ID number 2621082, was cloned from Methanobacterium thermoautotrophicum gil2621082 into a plasmid suitable for expression in E. coli., plasmid pZS*13S obtained from R. Lutz (Expressys, Germany) and are based on the pZ Expression System (Lutz, R. & Bujard, H., Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Res. 25, 1203-1210 (1997)).
E. coli (MG1655 variants) were transformed with the expression plasmid and selected and maintained using antibiotic selection with carbenicillin. Cells were grown in LB media with carbenicillin and IPTG at 37° C. then harvested by centrifugation. Lysis was performed using a chemical lysis procedure, and lysate the cooled to 4° C. Streptactin-tagged isopentenyl phosphate kinase was isolated from the cell lysate using Streptactin-Sepharose purification. Activity measurements on native substrate, isopentenyl phosphate, were performed to verify fidelity of the purified enzyme, using a pyruvate kinase-lactate dehydrogenase coupled assay to couple ADP formation from ATP to NADH oxidation. The same assay procedure was used to demonstrate robust activity on crotyl phosphate. In the absence of enzyme, no conversion of crotyl phosphate to crotyl diphosphate was observed (data not shown).
Isopentenyl-diphosphate DELTA-isomerase (IPP isomerase), E.C. 5.3.3.2, Genbank ID number 3790386, was cloned from Xanthophyllomyces dendrorhous into a plasmid suitable for expression in E. coli, plasmid pZS*13S obtained from R. Lutz (Expressys, Germany) and are based on the pZ Expression System (Lutz, R. & Bujard, H. Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Res. 25, 1203-1210 (1997)).
E. coli (MG1655 variants) were transformed with the expression plasmid and selected and maintained using antibiotic selection with carbenicillin. Cells were grown in LB media with carbenicillin and IPTG at 37° C. then harvested by centrifugation. Cell lysates containing the IPP isomerase from Xanthophyllomyces dendrorhous were generated by sonicating cells resuspended in 100 mM Tris, 50 mM KCl, 5 mM MgSO4, pH 7.2, and 5 mM DTT. 50 mM CrotOH was added to resulting cell lysate at 2.3 mg/ml total protein, and the reaction mixture incubated at 25° C. for 16 hours. The product of the isomerization reaction, MVC or 3-buten-2-ol, was detected at 1.2 mM by GCMS. In cell lysates devoid of the IPP isomerase, there was no detectable conversion of CrotOH to 3-buten-2-ol.
MVC or 3-buten-2-ol was measured using headspace analysis on an Agilent 7890A GC equipped with a CTC-PAL autosampler and a MSD (5975C). Samples were diluted 2-fold in 100% methanol to a total volume of 0.100 mL, and transferred into glass inserts in 1.5 mL GC vials. Samples were injected by a Combi PAL CTC autosampler operated in direct injection mode with an injection volume of 1.0 μL (split ratio 20:1) and 200° C. inlet temperature. Helium was used as a carrier gas, and the flow rate maintained at 1.28 mL/min. The oven temperature is initially held at 100° C. for 1 minute, then ramping 100° C./min to 230° C., for 3 minutes. The MVC or 3-buten-2-ol concentration in samples were calculated from calibration curves generated from diluted MVC standards analyzed under the same GCMS method.
The results of this example are presented in
Alcohol dehydrogenase, Genbank ID number 407959257, was cloned from Synechocystis sp. PCC 6803 into a plasmid suitable for expression in E. coli., plasmid pZS*13S obtained from R. Lutz (Expressys, Germany) and are based on the pZ Expression System (Lutz, R. & Bujard, H. Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Res. 25, 1203-1210 (1997)).
E. coli (MG1655 variants) were transformed with the expression plasmid and selected and maintained using antibiotic selection with carbenicillin. Cells were grown in LB media with carbenicillin and IPTG at 37° C. then harvested by centrifugation. Lysis was performed using a chemical lysis procedure, and lysate was then cooled to 4° C. Streptactin-tagged alcohol dehydrogenase was isolated from the cell lysate using Streptactin-Sepharose purification. Activity measurements assessing the NADPH-dependent reduction of crotonaldehyde to crotonol were performed. The alcohol dehydrogenase from Synechocystis sp. PCC 6803 was found to have a KM value of 0.16 mM and a Kcat of at least 36 s-1. In the absence of enzyme, no reduction of crotonaldehyde to crotonol was observed.
This application claims the benefit of U.S. Provisional Patent Application Ser. No. 62/020,901 filed Jul. 3, 2014, and U.S. Provisional Patent Application Ser. No. 62/082,747 filed Nov. 21, 2014, both applications entitled MICROORGANISMS FOR PRODUCING 4C-5C COMPOUNDS WITH UNSATURATION AND METHODS RELATED THERETO, the disclosures of which are incorporated herein by reference.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US15/39037 | 7/2/2015 | WO | 00 |
| Number | Date | Country | |
|---|---|---|---|
| 62020901 | Jul 2014 | US | |
| 62082747 | Nov 2014 | US |
